Surface AtlasMucinous colon cancer

Known interventions

Find interventions linked to a surface target in the campaign’s clinical-trial and ligand records. Open a record to inspect the reported target and source.

How interventions connect to targets

Recorded interventions

Interventions remain separate from target evidence and design proposals.
InterventionTarget(s)ActionFormatStatus
212Pb-DOTAM-GRPR1
Source studies (1)Record ID: I-CTG-212pb-dotam-grpr1-28e4663353
gastrin-releasing peptide receptorantagonist; radionuclide-deliveryradioligand-therapyRECRUITING
[111In]-FPI-1967
Source studies (1)Record ID: I-CTG-111in-fpi-1967-89b7f5ed6d
fibroblast growth factor receptor 3Not recordedmolecular-imaging-agentTERMINATED
[111In]-FPI-2107
Source studies (1)Record ID: I-CTG-111in-fpi-2107-37ea0ec994
epidermal growth factor receptor, hepatocyte growth factor receptorNot recordedmolecular-imaging-agentACTIVE_NOT_RECRUITING
[111In]In-DOTA-ANTI-CEA antibody injection
Source studies (1)Record ID: I-CTG-111in-in-dota-anti-cea-antibody-injection-db4657027f
carcinoembryonic antigen-related cell adhesion molecule 5Not recordedmolecular-imaging-agentUNKNOWN
[18F]F-RESCA-G5
Source studies (1)Record ID: I-CTG-18f-f-resca-g5-733d72e44e
glypican-3molecular-imagingmolecular-imaging-agentRECRUITING
[18F]F-RESCA-RB14
Source studies (1)Record ID: I-CTG-18f-f-resca-rb14-b3e631ee50
receptor tyrosine-protein kinase erbB-2molecular-imagingmolecular-imaging-agentRECRUITING
[18F]F-RESCA-RND20
Source studies (1)Record ID: I-CTG-18f-f-resca-rnd20-5136376ed7
nectin cell adhesion molecule 4molecular-imagingmolecular-imaging-agentRECRUITING
[18F]F-RESCA-T4
Source studies (2)Record ID: I-CTG-18f-f-resca-t4-35b147630c
tumor-associated calcium signal transducer 2molecular-imagingmolecular-imaging-agentRECRUITING
[18F]F-RESCA-WWH347
Source studies (1)Record ID: I-CTG-18f-f-resca-wwh347-2c82aa5ec4
cell surface A33 antigenmolecular-imagingmolecular-imaging-agentRECRUITING
[225Ac]-FPI-1966
Source studies (1)Record ID: I-CTG-225ac-fpi-1966-e299fbd736
fibroblast growth factor receptor 3Not recordedradioligand-therapyTERMINATED
[225Ac]-FPI-2068
Source studies (1)Record ID: I-CTG-225ac-fpi-2068-86d75ffcc8
epidermal growth factor receptor, hepatocyte growth factor receptorNot recordedradioligand-therapyACTIVE_NOT_RECRUITING
[68Ga]-NeoBOMB1
Source studies (1)Record ID: I-CTG-68ga-neobomb1-9353e21018
gastrin-releasing peptide receptorNot recordedmolecular-imaging-agentTERMINATED
[68Ga]Ga-DOTA-H2D3
Source studies (1)Record ID: I-CTG-68ga-ga-dota-h2d3-c90970f5a7
receptor tyrosine-protein kinase erbB-2molecular-imagingmolecular-imaging-agentRECRUITING
[68Ga]Ga-FL-261 PET Imaging / [111In]In-FL-261 SPECT Imaging
Source studies (1)Record ID: I-CTG-68ga-ga-fl-261-pet-imaging-111in-in-fl-261-1cd979f4ad
hepatocyte growth factor receptorNot recordedmolecular-imaging-agentRECRUITING
[68Ga]Ga-NOTA-G5
Source studies (1)Record ID: I-CTG-68ga-ga-nota-g5-6d44b3e9a5
glypican-3molecular-imagingmolecular-imaging-agentRECRUITING
[68Ga]Ga-NOTA-RND20
Source studies (1)Record ID: I-CTG-68ga-ga-nota-rnd20-882a3bd082
nectin cell adhesion molecule 4molecular-imagingmolecular-imaging-agentRECRUITING
[68Ga]Ga-NOTA-T4
Source studies (2)Record ID: I-CTG-68ga-ga-nota-t4-9e339e2328
tumor-associated calcium signal transducer 2molecular-imagingmolecular-imaging-agentRECRUITING
[68Ga]Ga-NOTA-WWH347
Source studies (1)Record ID: I-CTG-68ga-ga-nota-wwh347-6c428e5c54
cell surface A33 antigenmolecular-imagingmolecular-imaging-agentRECRUITING
A166
Source studies (1)Record ID: I-CTG-a166-64561330f1
receptor tyrosine-protein kinase erbB-2cytotoxic-payload-deliveryantibody-drug-conjugateCOMPLETED
AB680
Source studies (1)Record ID: I-CTG-ab680-d446c5ca53
ecto-5-prime-nucleotidaseinhibitorsmall-moleculeCOMPLETED
AMG 479
Source studies (2)Record ID: I-CTG-amg-479-f079f70775
insulin-like growth factor 1 receptorbinderantibodyCOMPLETED / TERMINATED
anti-CD133-CAR vector-transduced T cells
Source studies (1)Record ID: I-CTG-anti-cd133-car-vector-transduced-t-cells-71f6e37e6a
prominin-1Not recordedcar-t-cell-therapyCOMPLETED
anti-CEA CAR-T cells
Source studies (4)Record ID: I-CTG-anti-cea-car-t-cells-a8afa7bb5a
carcinoembryonic antigen-related cell adhesion molecule 5Not recordedcar-t-cell-therapyCOMPLETED / RECRUITING / WITHDRAWN
Anti-CEA-CAR T
Source studies (2)Record ID: I-CTG-anti-cea-car-t-7a15bcb339
carcinoembryonic antigen-related cell adhesion molecule 5Not recordedcar-t-cell-therapyUNKNOWN
anti-EGFR monoclonal antibody
Source studies (1)Record ID: I-CTG-anti-egfr-monoclonal-antibody-11294839cd
epidermal growth factor receptorNot recordedantibodyCOMPLETED
Anti-EGFR-Containing Regimen
Source studies (1)Record ID: I-CTG-anti-egfr-containing-regimen-079e0c7097
epidermal growth factor receptorNot recordedconventional-cytotoxic-regimenCOMPLETED
Anti-HER2 CAR-T
Source studies (1)Record ID: I-CTG-anti-her2-car-t-c75d83eaec
receptor tyrosine-protein kinase erbB-2Not recordedcar-t-cell-therapyWITHDRAWN
anti-MUC1 CAR-pNK cells
Source studies (1)Record ID: I-CTG-anti-muc1-car-pnk-cells-ec10721779
mucin-1Not recordedcar-nk-cell-therapyUNKNOWN
anti-MUC1 CAR-T cells
Source studies (1)Record ID: I-CTG-anti-muc1-car-t-cells-7dae37eda8
mucin-1Not recordedcar-t-cell-therapyUNKNOWN
anti-PD-1 antibody
Source studies (1)Record ID: I-CTG-anti-pd-1-antibody-0f75f0b392
programmed cell death protein 1Not recordedantibodyCOMPLETED
Anti-PD-1 monoclonal antibody
Source studies (1)Record ID: I-CTG-anti-pd-1-monoclonal-antibody-83ef48eab2
programmed cell death protein 1Not recordedantibodyUNKNOWN
Anti-PD-L1 Monoclonal Antibody
Source studies (1)Record ID: I-CTG-anti-pd-l1-monoclonal-antibody-b15c504477
programmed death-ligand 1Not recordedantibodyRECRUITING
Atezolizumab
Source studies (8)Record ID: I-CTG-atezolizumab-5dd1e8658b
programmed death-ligand 1binder; blocker; inhibitorantibodyACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED
avelumab
Source studies (5)Record ID: I-CTG-avelumab-b59aea15d3
programmed death-ligand 1binder; blockerantibodyCOMPLETED / TERMINATED / WITHDRAWN
Balstilimab
Source studies (3)Record ID: I-CTG-balstilimab-5a47b9bd23
programmed cell death protein 1Not recordedantibodyACTIVE_NOT_RECRUITING
CAR T cells
Source studies (1)Record ID: I-CTG-car-t-cells-c5bd1845e7
mesothelinNot recordedcar-t-cell-therapyUNKNOWN
CAR-T cell immunotherapy
Source studies (2)Record ID: I-CTG-car-t-cell-immunotherapy-1ef738f219
epithelial cell adhesion moleculeNot recordedcar-t-cell-therapyUNKNOWN
CAR-T cells targeting EpCAM
Source studies (1)Record ID: I-CTG-car-t-cells-targeting-epcam-552a0c6e28
epithelial cell adhesion moleculeNot recordedcar-t-cell-therapyUNKNOWN
CDH17 CAR-T
Source studies (1)Record ID: I-CTG-cdh17-car-t-5fafb7c24d
cadherin-17Not recordedcar-t-cell-therapyRECRUITING
CEA-targeted CAR-T cells
Source studies (5)Record ID: I-CTG-cea-targeted-car-t-cells-716275dc4a
carcinoembryonic antigen-related cell adhesion molecule 5Not recordedcar-t-cell-therapyCOMPLETED / RECRUITING / UNKNOWN
Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)]
Source studies (1)Record ID: I-CTG-cemiplimab-fianlimab-fixed-dose-combinatio-2883943204
cytotoxic T-lymphocyte protein 4, programmed cell death protein 1Not recordedother-or-unclearNOT_YET_RECRUITING
Cetuximab
Source studies (58)Record ID: I-CTG-cetuximab-22d728a3c3
epidermal growth factor receptorantagonist; binder; inhibitorantibodyACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN
Chimeric antigen receptor T cell preparation targeting GCC
Source studies (1)Record ID: I-CTG-chimeric-antigen-receptor-t-cell-preparati-2461b7b2f2
guanylate cyclase 2CNot recordedcar-t-cell-therapyUNKNOWN
CHM-2101 CAR-T cells
Source studies (1)Record ID: I-CTG-chm-2101-car-t-cells-1f528dedbe
cadherin-17Not recordedcar-t-cell-therapyRECRUITING
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A
Source studies (1)Record ID: I-CTG-copper-cu-64-anti-cea-monoclonal-antibody--1c38eaff9c
carcinoembryonic antigen-related cell adhesion molecule 5Not recordedantibodyACTIVE_NOT_RECRUITING
CP-751, 871
Source studies (1)Record ID: I-CTG-cp-751-871-7112346d32
insulin-like growth factor 1 receptorNot recordedantibodyCOMPLETED
CPI-006
Source studies (1)Record ID: I-CTG-cpi-006-7295548d5e
ecto-5-prime-nucleotidaseNot recordedantibodyCOMPLETED
CT-0508
Source studies (1)Record ID: I-CTG-ct-0508-e0402d4074
receptor tyrosine-protein kinase erbB-2Not recordedother-or-unclearUNKNOWN
Cu 64 anti-CEA monoclonal antibody M5A IV
Source studies (1)Record ID: I-CTG-cu-64-anti-cea-monoclonal-antibody-m5a-iv-ffd848d4d4
carcinoembryonic antigen-related cell adhesion molecule 5Not recordedantibodyACTIVE_NOT_RECRUITING
Datopotamab deruxtecan (Dato-DXd)
Source studies (1)Record ID: I-CTG-datopotamab-deruxtecan-dato-dxd-90cdcc43e0
tumor-associated calcium signal transducer 2Not recordedantibody-drug-conjugateRECRUITING
Durvalumab
Source studies (5)Record ID: I-CTG-durvalumab-a8c0108ba9
programmed death-ligand 1binder; blockerantibodyACTIVE_NOT_RECRUITING / COMPLETED
EB-DUO-CAR-NK-CEA/GCC
Source studies (1)Record ID: I-CTG-eb-duo-car-nk-cea-gcc-9ddb5588c2
carcinoembryonic antigen-related cell adhesion molecule 5, guanylate cyclase 2CNot recordedcar-nk-cell-therapyRECRUITING
EB-DUO-CAR-NK-CEA/GCC (IV)
Source studies (1)Record ID: I-CTG-eb-duo-car-nk-cea-gcc-iv-ea153d70da
carcinoembryonic antigen-related cell adhesion molecule 5, guanylate cyclase 2CNot recordedcar-nk-cell-therapyRECRUITING
EPCAM CAR-T
Source studies (1)Record ID: I-CTG-epcam-car-t-6e829ef49b
epithelial cell adhesion moleculeNot recordedcar-t-cell-therapyUNKNOWN
FAST LACO-Stim CDH17 CAR-T
Source studies (1)Record ID: I-CTG-fast-laco-stim-cdh17-car-t-41ef783a2e
cadherin-17Not recordedcar-t-cell-therapyRECRUITING
favezelimab/pembrolizumab
Source studies (2)Record ID: I-CTG-favezelimab-pembrolizumab-4da1038787
lymphocyte activation gene 3 protein, programmed cell death protein 1Not recordedbispecific-antibodyCOMPLETED
Fruquintinib combined with anti-PD-1 antibodies
Source studies (1)Record ID: I-CTG-fruquintinib-combined-with-anti-pd-1-antib-d7689fe1ff
programmed cell death protein 1Not recordedantibodyCOMPLETED
Ganitumab
Source studies (2)Record ID: I-CTG-ganitumab-5365bed8a8
insulin-like growth factor 1 receptorNot recordedantibodyCOMPLETED
IBI3028
Source studies (1)Record ID: I-CTG-ibi3028-ff981e0ea3
epidermal growth factor receptor, hepatocyte growth factor receptorcytotoxic-payload-deliveryantibody-drug-conjugateRECRUITING
IM96 CAR-T cells
Source studies (1)Record ID: I-CTG-im96-car-t-cells-111524d9e1
guanylate cyclase 2CNot recordedcar-t-cell-therapyUNKNOWN
Intraperitoneal infusion of FAST CEA-targeted CAR-T
Source studies (1)Record ID: I-CTG-intraperitoneal-infusion-of-fast-cea-targe-5d1a5c7453
carcinoembryonic antigen-related cell adhesion molecule 5Not recordedcar-t-cell-therapyRECRUITING
investigator choice re-challenge with anti EGFR Rx
Source studies (1)Record ID: I-CTG-investigator-choice-re-challenge-with-anti-9694a696df
epidermal growth factor receptorNot recordedantibodyUNKNOWN
iodine I 123 anti-CEA recombinant diabody T84.66
Source studies (1)Record ID: I-CTG-iodine-i-123-anti-cea-recombinant-diabody--bd95c1eb88
carcinoembryonic antigen-related cell adhesion molecule 5Not recordedmolecular-imaging-agentCOMPLETED
Iodine-124 labeled humanized A33 (antibody)
Source studies (1)Record ID: I-CTG-iodine-124-labeled-humanized-a33-antibody-e8caa6e23e
cell surface A33 antigenNot recordedmolecular-imaging-agentCOMPLETED
JS207
Source studies (1)Record ID: I-CTG-js207-13bb7c5a22
programmed cell death protein 1Not recordedbispecific-antibodyRECRUITING
JS212
Source studies (1)Record ID: I-CTG-js212-0f8ea7a70b
epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-3cytotoxic-payload-deliverybispecific-antibody-drug-conjugateRECRUITING
Keytruda
Source studies (1)Record ID: I-CTG-keytruda-8266394dac
programmed cell death protein 1binder; blockerantibodyNOT_YET_RECRUITING
KT032(anti-MSLN chimeric antigen receptor autologous T cell injection)
Source studies (1)Record ID: I-CTG-kt032-anti-msln-chimeric-antigen-receptor--6cffa98224
mesothelinNot recordedcar-t-cell-therapyNOT_YET_RECRUITING
long course radiotherapy + capecitabine + PD-1 monoclonal antibody treatment combinations
Source studies (1)Record ID: I-CTG-long-course-radiotherapy-capecitabine-pd-1-717aefe155
programmed cell death protein 1Not recordedantibodyUNKNOWN
Nimotuzumab
Source studies (1)Record ID: I-CTG-nimotuzumab-9d33f20df6
epidermal growth factor receptorNot recordedantibodyCOMPLETED
nivolumab
Source studies (22)Record ID: I-CTG-nivolumab-af64a27aa2
programmed cell death protein 1binder; blocker; inhibitorantibodyACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / SUSPENDED / TERMINATED / WITHDRAWN
Oleclumab
Source studies (2)Record ID: I-CTG-oleclumab-ad0acf4f20
ecto-5-prime-nucleotidaseNot recordedantibodyCOMPLETED
panitumumab
Source studies (14)Record ID: I-CTG-panitumumab-b41fb4011c
epidermal growth factor receptorantagonist; inhibitorantibodyACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / UNKNOWN
pembrolizumab
Source studies (23)Record ID: I-CTG-pembrolizumab-d8acadde7d
programmed cell death protein 1binder; inhibitorantibodyACTIVE_NOT_RECRUITING / COMPLETED / ENROLLING_BY_INVITATION / NOT_YET_RECRUITING / RECRUITING / TERMINATED / UNKNOWN
Pertuzumab
Source studies (4)Record ID: I-CTG-pertuzumab-fc1d976b9c
receptor tyrosine-protein kinase erbB-2Not recordedantibodyACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING
radionuclide imaging
Source studies (1)Record ID: I-CTG-radionuclide-imaging-4ddc489e17
carcinoembryonic antigen-related cell adhesion molecule 5Not recordedmolecular-imaging-agentACTIVE_NOT_RECRUITING
Ramucirumab
Source studies (2)Record ID: I-CTG-ramucirumab-3e3bf3aa35
vascular endothelial growth factor receptor 2Not recordedantibodyRECRUITING
Ramucirumab Injection [Cyramza]
Source studies (1)Record ID: I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c
vascular endothelial growth factor receptor 2antagonist; binder; blocker; inhibitorantibodyCOMPLETED
Recombinant Anti-EGFr Antibody
Source studies (1)Record ID: I-CTG-recombinant-anti-egfr-antibody-95e6a19c1f
epidermal growth factor receptorNot recordedantibodyCOMPLETED
Recombinant full human Anti-EGFR Monoclonal Antibody
Source studies (1)Record ID: I-CTG-recombinant-full-human-anti-egfr-monoclona-465bb5f843
epidermal growth factor receptorNot recordedantibodyUNKNOWN
Regorafenib
Source studies (6)Record ID: I-CTG-regorafenib-9aec6927fe
vascular endothelial growth factor receptor 2inhibitorsmall-moleculeACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING
regorafenib plus anti-PD-1 antibodies
Source studies (1)Record ID: I-CTG-regorafenib-plus-anti-pd-1-antibodies-89d65224dd
programmed cell death protein 1Not recordedantibodyCOMPLETED
sasanlimab
Source studies (2)Record ID: I-CTG-sasanlimab-dd86800660
programmed cell death protein 1Not recordedantibodyTERMINATED
SGM-101
Source studies (5)Record ID: I-CTG-sgm-101-3d31779152
carcinoembryonic antigen-related cell adhesion molecule 5molecular-imagingmolecular-imaging-agentCOMPLETED / RECRUITING / UNKNOWN
sintilimab
Source studies (2)Record ID: I-CTG-sintilimab-77dca9d617
programmed cell death protein 1Not recordedantibodyNOT_YET_RECRUITING / RECRUITING
Sintilimab (IBI308)+bevacizumab+oxaliplatin+capecitabine
Source studies (1)Record ID: I-CTG-sintilimab-ibi308-bevacizumab-oxaliplatin--9f8d711e91
programmed cell death protein 1Not recordedconventional-cytotoxic-regimenUNKNOWN
Sintilimab+mFOLFOX6 or FOLFIRI+bevacizumab or cetuximab
Source studies (1)Record ID: I-CTG-sintilimab-mfolfox6-or-folfiri-bevacizumab-6e665e903a
programmed cell death protein 1inhibitorconventional-cytotoxic-regimenRECRUITING
SOC (anti-PD-1 + platinum -based chemo)
Source studies (1)Record ID: I-CTG-soc-anti-pd-1-platinum-based-chemo-fa3d4d0cf3
programmed cell death protein 1Not recordedother-or-unclearTERMINATED
Standard-of-care treatment with panitumumab
Source studies (1)Record ID: I-CTG-standard-of-care-treatment-with-panitumuma-dd47c9ecad
epidermal growth factor receptorNot recordedantibodyCOMPLETED
Tislelizumab
Source studies (3)Record ID: I-CTG-tislelizumab-45f8cec74e
programmed cell death protein 1inhibitorantibodyACTIVE_NOT_RECRUITING / RECRUITING / TERMINATED
TQB2102 Injection
Source studies (1)Record ID: I-CTG-tqb2102-injection-fe523b8bde
receptor tyrosine-protein kinase erbB-2cytotoxic-payload-deliveryantibody-drug-conjugateNOT_YET_RECRUITING
TQB2618 injection
Source studies (1)Record ID: I-CTG-tqb2618-injection-1e9a8d0d95
T-cell immunoglobulin and mucin-domain containing-3Not recordedantibodyUNKNOWN
TQB2922 injection ± TAS-102 tablets
Source studies (1)Record ID: I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f
epidermal growth factor receptor, hepatocyte growth factor receptorbinder; blockerbispecific-antibodyRECRUITING
TQB2922 injection+TAS-102 tablets ± Bevacizumab
Source studies (1)Record ID: I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d
epidermal growth factor receptor, hepatocyte growth factor receptorbinder; blockerbispecific-antibodyRECRUITING
TQB2930 injection + Oxaliplatin injection + Capecitabine tablets
Source studies (1)Record ID: I-CTG-tqb2930-injection-oxaliplatin-injection-ca-64a50abf1a
receptor tyrosine-protein kinase erbB-2binderconventional-cytotoxic-regimenNOT_YET_RECRUITING
TQB2930 injection + Oxaliplatin injection + Capecitabine tablets + Bevacizumab injection
Source studies (1)Record ID: I-CTG-tqb2930-injection-oxaliplatin-injection-ca-f14a3dfa1c
receptor tyrosine-protein kinase erbB-2binderconventional-cytotoxic-regimenNOT_YET_RECRUITING
trastuzumab
Source studies (9)Record ID: I-CTG-trastuzumab-672bb991dc
receptor tyrosine-protein kinase erbB-2inhibitorantibodyACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / WITHDRAWN
tucatinib
Source studies (3)Record ID: I-CTG-tucatinib-096d38d2ad
receptor tyrosine-protein kinase erbB-2Not recordedsmall-moleculeACTIVE_NOT_RECRUITING / RECRUITING / WITHDRAWN
vobramitamab duocarmazine
Source studies (1)Record ID: I-CTG-vobramitamab-duocarmazine-50a4e37d35
CD276 antigenNot recordedantibody-drug-conjugateTERMINATED
vobramitamab duocarmazine 2.0 mg (Arm A)
Source studies (1)Record ID: I-CTG-vobramitamab-duocarmazine-2-0-mg-arm-a-070889dad2
CD276 antigenNot recordedantibody-drug-conjugateTERMINATED
vobramitamab duocarmazine 2.7 mg (Arm B)
Source studies (1)Record ID: I-CTG-vobramitamab-duocarmazine-2-7-mg-arm-b-61467fa51b
CD276 antigenNot recordedantibody-drug-conjugateTERMINATED
vofatamab
Source studies (1)Record ID: I-CTG-vofatamab-eb0c930491
fibroblast growth factor receptor 3Not recordedantibodyTERMINATED
yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A
Source studies (1)Record ID: I-CTG-yttrium-y-90-dota-anti-cea-monoclonal-anti-961f658b9c
carcinoembryonic antigen-related cell adhesion molecule 5Not recordedradioligand-therapyCOMPLETED
Zanidatamab
Source studies (3)Record ID: I-CTG-zanidatamab-ab22a9e067
receptor tyrosine-protein kinase erbB-2Not recordedbispecific-antibodyRECRUITING
Zimberelimab
Source studies (1)Record ID: I-CTG-zimberelimab-7422e0c132
programmed cell death protein 1Not recordedantibodyCOMPLETED
αPD1-MSLN-CAR T cells
Source studies (1)Record ID: I-CTG-pd1-msln-car-t-cells-2d2d907322
mesothelinNot recordedcar-t-cell-therapyUNKNOWN
[111In]-FPI-2058
Source studies (1)Record ID: I-CTG-111in-fpi-2058-acfaea1b28
neurotensin receptor 1molecular-imagingmolecular-imaging-agentTERMINATED
[225]-FPI-2059
Source studies (1)Record ID: I-CTG-225-fpi-2059-cbaa866dc3
neurotensin receptor 1radionuclide-deliveryradioligand-therapyTERMINATED
AMG 655
Source studies (2)Record ID: I-CTG-amg-655-488f67c71e
tumor necrosis factor receptor superfamily member 10BbinderantibodyCOMPLETED / TERMINATED
anti-CTLA-4 antibody
Source studies (1)Record ID: I-CTG-anti-ctla-4-antibody-d6dc4b60f3
cytotoxic T-lymphocyte protein 4Not recordedantibodyCOMPLETED
Anti-SEMA4D Monoclonal Antibody VX15/2503
Source studies (1)Record ID: I-CTG-anti-sema4d-monoclonal-antibody-vx15-2503-7692562550
semaphorin-4DNot recordedantibodyCOMPLETED
Avastin
Source studies (1)Record ID: I-CTG-avastin-f9a8fcc9c3
vascular endothelial growth factor ANot recordedantibodyTERMINATED
Bevacizumab
Source studies (42)Record ID: I-CTG-bevacizumab-8446a83051
vascular endothelial growth factor Ablocker; inhibitorantibodyACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN
Bevacizumab Biosimilar
Source studies (1)Record ID: I-CTG-bevacizumab-biosimilar-a36da74e4d
vascular endothelial growth factor ANot recordedantibodyNOT_YET_RECRUITING
Bevacizumab Injection
Source studies (3)Record ID: I-CTG-bevacizumab-injection-b001eba9fa
vascular endothelial growth factor ANot recordedantibodyCOMPLETED / SUSPENDED / UNKNOWN
Botensilimab
Source studies (3)Record ID: I-CTG-botensilimab-fc49d21f07
cytotoxic T-lymphocyte protein 4Not recordedantibodyACTIVE_NOT_RECRUITING
CAR-T infusion
Source studies (1)Record ID: I-CTG-car-t-infusion-933023072e
NKG2-D type II integral membrane proteinNot recordedcar-nk-cell-therapyUNKNOWN
Claudin18.2-targeted CAR-DCs
Source studies (1)Record ID: I-CTG-claudin18-2-targeted-car-dcs-af64bdaa0d
claudin-18 isoform 2Not recordedcellular-therapyRECRUITING
Claudin18.2-targeted CAR-T Cells
Source studies (1)Record ID: I-CTG-claudin18-2-targeted-car-t-cells-84d6f72ad0
claudin-18 isoform 2Not recordedcar-t-cell-therapyRECRUITING
CNTO 328; Anti-interleukin-6 monoclonal antibody
Source studies (1)Record ID: I-CTG-cnto-328-anti-interleukin-6-monoclonal-ant-18a7114fa4
interleukin-6Not recordedantibodyCOMPLETED
Etrumadenant
Source studies (1)Record ID: I-CTG-etrumadenant-9cc45271d9
adenosine A2A receptor, adenosine A2B receptorantagonistsmall-moleculeCOMPLETED
Fruquintinib
Source studies (3)Record ID: I-CTG-fruquintinib-990786ee64
vascular endothelial growth factor receptor familyinhibitorsmall-moleculeACTIVE_NOT_RECRUITING / NOT_YET_RECRUITING / RECRUITING
INBRX-109
Source studies (1)Record ID: I-CTG-inbrx-109-fb6bab3c3e
tumor necrosis factor receptor superfamily member 10Bagonistother-or-unclearRECRUITING
Ipilimumab
Source studies (15)Record ID: I-CTG-ipilimumab-b766c43ce0
cytotoxic T-lymphocyte protein 4binder; blockerantibodyACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / WITHDRAWN
NKG2D CAR-NK
Source studies (1)Record ID: I-CTG-nkg2d-car-nk-f396e4aac1
NKG2-D type II integral membrane proteinNot recordedcar-nk-cell-therapyUNKNOWN
Tiragolumab
Source studies (2)Record ID: I-CTG-tiragolumab-dd38477944
T-cell immunoreceptor with Ig and ITIM domainsinhibitorantibodyACTIVE_NOT_RECRUITING / RECRUITING
Tocilizumab
Source studies (2)Record ID: I-CTG-tocilizumab-85bf04378e
interleukin-6 receptor subunit alphaNot recordedantibodyTERMINATED
Trifluridine /Tipiracil (TAS-102) tablets / Fruquintinib / Regorafenib tablets
Source studies (1)Record ID: I-CTG-trifluridine-tipiracil-tas-102-tablets-fru-6a185e2f56
vascular endothelial growth factor receptor familyblocker; inhibitorsmall-moleculeNOT_YET_RECRUITING
TTX-080
Source studies (1)Record ID: I-CTG-ttx-080-be60161d02
HLA class I histocompatibility antigen, alpha chain GNot recordedantibodyRECRUITING
(Early) Imaging of response with [18F-]-FDG PET-CT and kinase activity profiles
Source studies (1)Record ID: I-CTG-early-imaging-of-response-with-18f-fdg-pet-4fdfa2a180
Not recordedNot recordedmolecular-imaging-agentCOMPLETED
1 mg 89Zr-DFO-Nimotuzumab
Source studies (1)Record ID: I-CTG-1-mg-89zr-dfo-nimotuzumab-ad74941ac3
Not recordedNot recordedother-or-unclearRECRUITING
111Indium CHX-A
Source studies (1)Record ID: I-CTG-111indium-chx-a-65ae89ac97
Not recordedNot recordedother-or-unclearTERMINATED
120mg Regorafenib at week2
Source studies (1)Record ID: I-CTG-120mg-regorafenib-at-week2-4113c8b27c
Not recordedNot recordedsmall-moleculeWITHDRAWN
160 mg Regorafenib at week 3
Source studies (1)Record ID: I-CTG-160-mg-regorafenib-at-week-3-cd13ed6b64
Not recordedNot recordedsmall-moleculeWITHDRAWN
177Lu-BetaBart
Source studies (1)Record ID: I-CTG-177lu-betabart-fb338b61db
Not recordedNot recordedradioligand-therapyRECRUITING
18F-FDG
Source studies (1)Record ID: I-CTG-18f-fdg-8a2b994805
Not recordedNot recordedmolecular-imaging-agentACTIVE_NOT_RECRUITING
18F-αvβ6-BP
Source studies (1)Record ID: I-CTG-18f-v-6-bp-08e45d3cef
Not recordedNot recordedmolecular-imaging-agentACTIVE_NOT_RECRUITING
1H Spectroscopy at 1.5T and 3T
Source studies (1)Record ID: I-CTG-1h-spectroscopy-at-1-5t-and-3t-d2b75d3f74
Not recordedNot recordedprocedure-or-deviceCOMPLETED
203Pb-DOTAM
Source studies (1)Record ID: I-CTG-203pb-dotam-965dd78c82
Not recordedNot recordedother-or-unclearRECRUITING
212Pb-DOTAM
Source studies (1)Record ID: I-CTG-212pb-dotam-a9d2afc7be
Not recordedNot recordedradioligand-therapyRECRUITING
350 mg leronlimab
Source studies (1)Record ID: I-CTG-350-mg-leronlimab-788ba15886
Not recordedNot recordedantibodyACTIVE_NOT_RECRUITING
5-Fluorouracil
Source studies (5)Record ID: I-CTG-5-fluorouracil-54c81ae48b
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED / RECRUITING / TERMINATED
5-Fluorouracil (5-FU)
Source studies (1)Record ID: I-CTG-5-fluorouracil-5-fu-70024f00b0
Not recordedNot recordedconventional-cytotoxic-regimenWITHDRAWN
5-Fluouracil
Source studies (1)Record ID: I-CTG-5-fluouracil-02062800ef
Not recordedNot recordedother-or-unclearCOMPLETED
5-FU
Source studies (5)Record ID: I-CTG-5-fu-e38b30c404
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED / UNKNOWN
5-FU/LV
Source studies (1)Record ID: I-CTG-5-fu-lv-7780ef39f8
Not recordedNot recordedother-or-unclearCOMPLETED
5-HT3 antagonist
Source studies (1)Record ID: I-CTG-5-ht3-antagonist-70ee71046f
Not recordedantagonistother-or-unclearCOMPLETED
50 mg 89Zr-DFO-Nimotuzumab
Source studies (1)Record ID: I-CTG-50-mg-89zr-dfo-nimotuzumab-97671e4dcf
Not recordedNot recordedother-or-unclearRECRUITING
5FU/LV
Source studies (1)Record ID: I-CTG-5fu-lv-6f078c1a90
Not recordedNot recordedother-or-unclearRECRUITING
6-month adjuvant chemotherapy with 5-FU monotherapy
Source studies (1)Record ID: I-CTG-6-month-adjuvant-chemotherapy-with-5-fu-mo-10b1416de5
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
700 mg leronlimab
Source studies (1)Record ID: I-CTG-700-mg-leronlimab-38a4c1ed26
Not recordedNot recordedantibodyACTIVE_NOT_RECRUITING
700mg leronlimab weekly dose
Source studies (1)Record ID: I-CTG-700mg-leronlimab-weekly-dose-cda1c365e6
Not recordedNot recordedantibodyWITHDRAWN
80mg Regorafenib at week 1
Source studies (1)Record ID: I-CTG-80mg-regorafenib-at-week-1-ad37cdaf9e
Not recordedNot recordedsmall-moleculeWITHDRAWN
9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
Source studies (1)Record ID: I-CTG-9-valent-human-papillomavirus-types-6-11-1-25b4049687
Not recordedNot recordedvaccineACTIVE_NOT_RECRUITING
[177Lu]Lu-A9-0631
Source studies (1)Record ID: I-CTG-177lu-lu-a9-0631-66f6221fe7
Not recordedNot recordedradioligand-therapyRECRUITING
[18F]F-RESCA-EPCD6
Source studies (1)Record ID: I-CTG-18f-f-resca-epcd6-8dea9211d8
Not recordedNot recordedmolecular-imaging-agentRECRUITING
[18F]F-RESCA-RT4
Source studies (1)Record ID: I-CTG-18f-f-resca-rt4-052aca8d82
Not recordedNot recordedmolecular-imaging-agentRECRUITING
[225Ac]Ac-A9-0642
Source studies (1)Record ID: I-CTG-225ac-ac-a9-0642-acd879c5d4
Not recordedNot recordedradioligand-therapyRECRUITING
[225Ac]Ac-AKY-1189 (therapeutic)
Source studies (1)Record ID: I-CTG-225ac-ac-aky-1189-therapeutic-e092f13cd1
Not recordedNot recordedradioligand-therapyRECRUITING
[64Cu]Cu-AKY-1189 (imaging)
Source studies (1)Record ID: I-CTG-64cu-cu-aky-1189-imaging-45a8ab64f4
Not recordedNot recordedmolecular-imaging-agentRECRUITING
[68Ga]Ga-A9-6217
Source studies (1)Record ID: I-CTG-68ga-ga-a9-6217-28ce6e0997
Not recordedNot recordedmolecular-imaging-agentRECRUITING
[68Ga]Ga-NOTA-EPCD6
Source studies (1)Record ID: I-CTG-68ga-ga-nota-epcd6-c3b6b40e63
Not recordedNot recordedmolecular-imaging-agentRECRUITING
[68Ga]Ga-NOTA-RT4
Source studies (1)Record ID: I-CTG-68ga-ga-nota-rt4-fdc302ba89
Not recordedNot recordedmolecular-imaging-agentRECRUITING
A2B530
Source studies (1)Record ID: I-CTG-a2b530-dd25994920
Not recordedNot recordedcar-t-cell-therapyACTIVE_NOT_RECRUITING
AB122
Source studies (1)Record ID: I-CTG-ab122-90ee1bf613
Not recordedNot recordedother-or-unclearRECRUITING
AB154
Source studies (1)Record ID: I-CTG-ab154-b162427726
Not recordedNot recordedother-or-unclearRECRUITING
ABBV-621
Source studies (1)Record ID: I-CTG-abbv-621-145a5a1d8e
Not recordedNot recordedother-or-unclearCOMPLETED
Abemaciclib
Source studies (1)Record ID: I-CTG-abemaciclib-1354cf6146
Not recordedNot recordedother-or-unclearRECRUITING
Abiraterone
Source studies (1)Record ID: I-CTG-abiraterone-6f8c767b5d
Not recordedNot recordedother-or-unclearTERMINATED
Abiraterone Acetate
Source studies (1)Record ID: I-CTG-abiraterone-acetate-be32af7aa2
Not recordedNot recordedother-or-unclearCOMPLETED
Ablation
Source studies (1)Record ID: I-CTG-ablation-d5288a34c4
Not recordedNot recordedprocedure-or-deviceCOMPLETED
ABX-EGF
Source studies (1)Record ID: I-CTG-abx-egf-dc1ceaee75
Not recordedNot recordedother-or-unclearCOMPLETED
Active surveillance
Source studies (1)Record ID: I-CTG-active-surveillance-4d63f5a6e2
Not recordedNot recordedother-or-unclearRECRUITING
ACZ885
Source studies (1)Record ID: I-CTG-acz885-94eb7288a5
Not recordedNot recordedother-or-unclearCOMPLETED
Adenorine
Source studies (1)Record ID: I-CTG-adenorine-b88c9ce4cd
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5
Source studies (1)Record ID: I-CTG-adenovirus-5-cea-muc1-brachyury-vaccine-tr-871a711d3a
Not recordedNot recordedvaccineACTIVE_NOT_RECRUITING
Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
Source studies (1)Record ID: I-CTG-adenovirus-5-f35-human-guanylyl-cyclase-c--cfef342113
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Adjuvant chemoradiotherapy
Source studies (1)Record ID: I-CTG-adjuvant-chemoradiotherapy-4f2ba517df
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
adjuvant therapy
Source studies (1)Record ID: I-CTG-adjuvant-therapy-fa8e84690a
Not recordedNot recordedprocedure-or-deviceCOMPLETED
Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cell
Source studies (1)Record ID: I-CTG-adoptive-cell-transfer-of-nkg2dl-targettin-a7524f38de
Not recordedNot recordedcar-t-cell-therapyUNKNOWN
Adoptive Immunotherapy
Source studies (1)Record ID: I-CTG-adoptive-immunotherapy-f363a01a06
Not recordedNot recordedother-or-unclearTERMINATED
Adverse event
Source studies (1)Record ID: I-CTG-adverse-event-0176fffe25
Not recordedNot recordedother-or-unclearUNKNOWN
Aflibercept
Source studies (1)Record ID: I-CTG-aflibercept-0ebf41ec93
Not recordedNot recordedother-or-unclearCOMPLETED
Aflibercept AVE0005
Source studies (1)Record ID: I-CTG-aflibercept-ave0005-bd9bb07c15
Not recordedNot recordedother-or-unclearTERMINATED
AK104 injection
Source studies (1)Record ID: I-CTG-ak104-injection-212be18ed8
Not recordedNot recordedconventional-cytotoxic-regimenNOT_YET_RECRUITING
Aldesleukin
Source studies (5)Record ID: I-CTG-aldesleukin-953b24ad52
Not recordedNot recordedcellular-therapyRECRUITING / TERMINATED
ALT-803
Source studies (1)Record ID: I-CTG-alt-803-14dbe0617e
Not recordedNot recordedother-or-unclearWITHDRAWN
ALT803
Source studies (1)Record ID: I-CTG-alt803-664ec51b87
Not recordedNot recordedother-or-unclearCOMPLETED
ALX148
Source studies (1)Record ID: I-CTG-alx148-e9f16593fa
Not recordedNot recordedother-or-unclearRECRUITING
AMG 706
Source studies (1)Record ID: I-CTG-amg-706-402c244e95
Not recordedinhibitorsmall-moleculeCOMPLETED
Aminolevulinic Acid
Source studies (1)Record ID: I-CTG-aminolevulinic-acid-26266e8895
Not recordedNot recordedother-or-unclearRECRUITING
Amivantamab
Source studies (1)Record ID: I-CTG-amivantamab-3efdc81039
Not recordedNot recordedantibodyTERMINATED
Andes-1537 for Injection
Source studies (1)Record ID: I-CTG-andes-1537-for-injection-95f88580f3
Not recordedNot recordedother-or-unclearCOMPLETED
Anlotinib hydrochloride capsules
Source studies (1)Record ID: I-CTG-anlotinib-hydrochloride-capsules-8604440201
Not recordedNot recordedsmall-moleculeUNKNOWN
anti-Kirsten rat sarcoma virus (KRAS) Glycine(G) to Aspartic Acid(D) substitution at codon 12 peripheral blood lymphocytes (PBL)
Source studies (1)Record ID: I-CTG-anti-kirsten-rat-sarcoma-virus-kras-glycin-147f0492e0
Not recordedNot recordedother-or-unclearTERMINATED
Anti-KRAS G12V mTCR PBL
Source studies (1)Record ID: I-CTG-anti-kras-g12v-mtcr-pbl-93878ef2b4
Not recordedNot recordedother-or-unclearRECRUITING
Apatinib Mesylate Tablets
Source studies (2)Record ID: I-CTG-apatinib-mesylate-tablets-4e0201acc6
Not recordedNot recordedconventional-cytotoxic-regimenSUSPENDED / UNKNOWN
Apheresis
Source studies (1)Record ID: I-CTG-apheresis-ed41b65a76
Not recordedNot recordedother-or-unclearRECRUITING
Aprepitant
Source studies (1)Record ID: I-CTG-aprepitant-787ff3ff6c
Not recordedNot recordedother-or-unclearCOMPLETED
artificial intelligence system
Source studies (1)Record ID: I-CTG-artificial-intelligence-system-9c12a4b349
Not recordedNot recordeddiagnostic-testCOMPLETED
ASP1002
Source studies (1)Record ID: I-CTG-asp1002-6134c9a134
Not recordedNot recordedother-or-unclearRECRUITING
ATRC-101
Source studies (1)Record ID: I-CTG-atrc-101-68cdc8775f
Not recordedNot recordedantibodyTERMINATED
autologous dendritic cell vaccination
Source studies (1)Record ID: I-CTG-autologous-dendritic-cell-vaccination-078253425d
Not recordedNot recordedvaccineCOMPLETED
autologous dendritic cells loaded with autologous tumour homogenate
Source studies (1)Record ID: I-CTG-autologous-dendritic-cells-loaded-with-aut-0ac8911b52
Not recordedNot recordedvaccineRECRUITING
Autologous hematopoietic and immune cell rescue (transplantation)
Source studies (1)Record ID: I-CTG-autologous-hematopoietic-and-immune-cell-r-2ddcee3f25
Not recordedNot recordedprocedure-or-deviceWITHDRAWN
Autologous tumor cell + CpG vaccine
Source studies (1)Record ID: I-CTG-autologous-tumor-cell-cpg-vaccine-75a426cf64
Not recordedNot recordedvaccineWITHDRAWN
AZD4635
Source studies (1)Record ID: I-CTG-azd4635-ee309fd293
Not recordedNot recordedother-or-unclearCOMPLETED
BAY 43-9006
Source studies (1)Record ID: I-CTG-bay-43-9006-32706741de
Not recordedNot recordedother-or-unclearCOMPLETED
BAY2927088
Source studies (1)Record ID: I-CTG-bay2927088-10eedb2ea7
Not recordedNot recordedother-or-unclearRECRUITING
Best supportive care
Source studies (1)Record ID: I-CTG-best-supportive-care-8f032e0c75
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Best Supportive Care (BSC)
Source studies (1)Record ID: I-CTG-best-supportive-care-bsc-e0cd284b91
Not recordedNot recordedother-or-unclearCOMPLETED
BET Bromodomain Inhibitor ZEN-3694
Source studies (1)Record ID: I-CTG-bet-bromodomain-inhibitor-zen-3694-3b8be26ce3
Not recordedinhibitorother-or-unclearRECRUITING
Bevacizumab + Capecitabine + Radiotherapy
Source studies (1)Record ID: I-CTG-bevacizumab-capecitabine-radiotherapy-6e5e021cd4
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Bevacizumab in combination with chemotherapy based on fluoropyrimidine IV
Source studies (1)Record ID: I-CTG-bevacizumab-in-combination-with-chemothera-9b51bb8bfe
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Bevacizumab injection(Avastin)
Source studies (1)Record ID: I-CTG-bevacizumab-injection-avastin-cb4c34f227
Not recordedNot recordedantibodyCOMPLETED
Bevacizumab-containing regimen
Source studies (1)Record ID: I-CTG-bevacizumab-containing-regimen-3d791f39a9
Not recordedNot recordedother-or-unclearCOMPLETED
BIBW 2992
Source studies (1)Record ID: I-CTG-bibw-2992-4416ed0aea
Not recordedNot recordedother-or-unclearCOMPLETED
binimetinib
Source studies (3)Record ID: I-CTG-binimetinib-fc88a18a7b
Not recordedNot recordedother-or-unclearCOMPLETED / TERMINATED / WITHDRAWN
Biomarker
Source studies (1)Record ID: I-CTG-biomarker-78a06ba58b
Not recordedNot recordedother-or-unclearUNKNOWN
Biopsy
Source studies (3)Record ID: I-CTG-biopsy-9621fbc743
Not recordedNot recordedprocedure-or-deviceCOMPLETED / RECRUITING / TERMINATED
Biopsy Procedure
Source studies (9)Record ID: I-CTG-biopsy-procedure-426e7eb4e9
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING / RECRUITING
Biospecimen Collection
Source studies (17)Record ID: I-CTG-biospecimen-collection-4197a4ebc7
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING / RECRUITING / TERMINATED / WITHDRAWN
BLOOD AND TUMOR
Source studies (1)Record ID: I-CTG-blood-and-tumor-10e5261d4d
Not recordedNot recordedprocedure-or-deviceRECRUITING
Blood Collection for Plasma ctDNA
Source studies (1)Record ID: I-CTG-blood-collection-for-plasma-ctdna-c06f923009
Not recordedNot recordedother-or-unclearRECRUITING
blood pressure measurement
Source studies (1)Record ID: I-CTG-blood-pressure-measurement-e479a7af1e
Not recordedNot recordedother-or-unclearCOMPLETED
Blood sample
Source studies (1)Record ID: I-CTG-blood-sample-c4e8a6bf03
Not recordedNot recordeddiagnostic-testACTIVE_NOT_RECRUITING
Blood sampling
Source studies (1)Record ID: I-CTG-blood-sampling-8397318160
Not recordedNot recordedother-or-unclearCOMPLETED
Blood test
Source studies (1)Record ID: I-CTG-blood-test-b2571e0e22
Not recordedNot recordedcellular-therapyCOMPLETED
Bone Marrow Biopsy
Source studies (1)Record ID: I-CTG-bone-marrow-biopsy-d361d304aa
Not recordedNot recordedprocedure-or-deviceTERMINATED
Bone Scan
Source studies (1)Record ID: I-CTG-bone-scan-76e68ecb1f
Not recordedNot recordedprocedure-or-deviceRECRUITING
Bortezomib
Source studies (1)Record ID: I-CTG-bortezomib-080fc3cced
Not recordedNot recordedconventional-cytotoxic-regimenUNKNOWN
BTG-002814
Source studies (1)Record ID: I-CTG-btg-002814-7ade8f054d
Not recordedNot recordedother-or-unclearCOMPLETED
BVAC-B
Source studies (1)Record ID: I-CTG-bvac-b-af1d5fe703
Not recordedNot recordedother-or-unclearCOMPLETED
BW and height
Source studies (1)Record ID: I-CTG-bw-and-height-f41a2fad6d
Not recordedNot recordedother-or-unclearUNKNOWN
BYL719
Source studies (1)Record ID: I-CTG-byl719-94ba9da64b
Not recordedNot recordedother-or-unclearCOMPLETED
Cabozantinib
Source studies (1)Record ID: I-CTG-cabozantinib-c1202a0fd8
Not recordedbinder; inhibitorother-or-unclearACTIVE_NOT_RECRUITING
CAdVEC
Source studies (1)Record ID: I-CTG-cadvec-b1e763cb1d
Not recordedNot recordedother-or-unclearRECRUITING
cancer stem cell vaccine
Source studies (1)Record ID: I-CTG-cancer-stem-cell-vaccine-c02a83eda3
Not recordedNot recordedvaccineCOMPLETED
Cannabidiol
Source studies (1)Record ID: I-CTG-cannabidiol-763c603576
Not recordedNot recordedother-or-unclearUNKNOWN
capecitabine
Source studies (21)Record ID: I-CTG-capecitabine-c72c76a9c0
Not recordedNot recordedconventional-cytotoxic-regimenACTIVE_NOT_RECRUITING / COMPLETED / NOT_YET_RECRUITING / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN
Capecitabine + Radiotherapy
Source studies (1)Record ID: I-CTG-capecitabine-radiotherapy-b30419b255
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
CapeOx
Source studies (1)Record ID: I-CTG-capeox-aa8e491416
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
capillaroscopy
Source studies (1)Record ID: I-CTG-capillaroscopy-2022d7eaf9
Not recordedNot recordedother-or-unclearCOMPLETED
CAR-T cell
Source studies (1)Record ID: I-CTG-car-t-cell-14e8e8d819
Not recordedNot recordedcar-t-cell-therapyUNKNOWN
Carboplatin
Source studies (7)Record ID: I-CTG-carboplatin-fcaf0e1c36
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING / TERMINATED
Carboplatin + Pemetrexed + Pembrolizumab
Source studies (1)Record ID: I-CTG-carboplatin-pemetrexed-pembrolizumab-bfcbee9719
Not recordedNot recordedother-or-unclearRECRUITING
CEA-loaded dendritic cell vaccine
Source studies (1)Record ID: I-CTG-cea-loaded-dendritic-cell-vaccine-88a88d2400
Not recordedNot recordedvaccineCOMPLETED
Cediranib
Source studies (1)Record ID: I-CTG-cediranib-2c3f197078
Not recordedbinder; inhibitorsmall-moleculeACTIVE_NOT_RECRUITING
Celecoxib
Source studies (1)Record ID: I-CTG-celecoxib-de59c17075
Not recordedNot recordedother-or-unclearCOMPLETED
Cemiplimab
Source studies (1)Record ID: I-CTG-cemiplimab-21fb1ce506
Not recordedNot recordedother-or-unclearRECRUITING
cemiplimab + REGN7075
Source studies (1)Record ID: I-CTG-cemiplimab-regn7075-229dd94a54
Not recordedNot recordedother-or-unclearRECRUITING
cemiplimab plus fianlimab
Source studies (1)Record ID: I-CTG-cemiplimab-plus-fianlimab-273c96b045
Not recordedNot recordedother-or-unclearRECRUITING
Cetuximab (Erbitux)
Source studies (1)Record ID: I-CTG-cetuximab-erbitux-a5910d5bf7
Not recordedNot recordedother-or-unclearCOMPLETED
cetuximab and lapatinib
Source studies (1)Record ID: I-CTG-cetuximab-and-lapatinib-92aa5f1a93
Not recordedNot recordedother-or-unclearCOMPLETED
Cetuximab and Radiation Therapy
Source studies (1)Record ID: I-CTG-cetuximab-and-radiation-therapy-2fd470462b
Not recordedNot recordedother-or-unclearWITHDRAWN
Cetuximab injection
Source studies (1)Record ID: I-CTG-cetuximab-injection-49d9830a2d
Not recordedNot recordedother-or-unclearCOMPLETED
Cetuximab, irinotecan
Source studies (1)Record ID: I-CTG-cetuximab-irinotecan-3bb2b8cb08
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Cetuximab/Gefitinib combination and/or monotherapy
Source studies (1)Record ID: I-CTG-cetuximab-gefitinib-combination-and-or-mon-c7431b06f0
Not recordedNot recordedother-or-unclearCOMPLETED
Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy
Source studies (1)Record ID: I-CTG-checkpoint-inhibitor-cpi-such-as-pembroliz-b7de134724
Not recordedinhibitorconventional-cytotoxic-regimenRECRUITING
Chemoradiotherapy plus Bevacizumab
Source studies (1)Record ID: I-CTG-chemoradiotherapy-plus-bevacizumab-4cc222d1f2
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Chemotherapy
Source studies (3)Record ID: I-CTG-chemotherapy-ec0f3b0bd1
Not recordedNot recordedconventional-cytotoxic-regimenACTIVE_NOT_RECRUITING / COMPLETED / UNKNOWN
Chemotherapy Drugs
Source studies (1)Record ID: I-CTG-chemotherapy-drugs-94ae93efe0
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
chemotherapy in combination with trastuzumab for arm1
Source studies (1)Record ID: I-CTG-chemotherapy-in-combination-with-trastuzum-1a4b4db3d3
Not recordedNot recordedconventional-cytotoxic-regimenUNKNOWN
chemotherapy in combination with trastuzumab for arm2
Source studies (1)Record ID: I-CTG-chemotherapy-in-combination-with-trastuzum-18646cd401
Not recordedNot recordedconventional-cytotoxic-regimenUNKNOWN
chemotherapy in combination with trastuzumab for arm3
Source studies (1)Record ID: I-CTG-chemotherapy-in-combination-with-trastuzum-b750fc0438
Not recordedNot recordedconventional-cytotoxic-regimenUNKNOWN
chemotherapy in combination with trastuzumab for arm4
Source studies (1)Record ID: I-CTG-chemotherapy-in-combination-with-trastuzum-0327251cbb
Not recordedNot recordedconventional-cytotoxic-regimenUNKNOWN
chemotherapy plus bevacizumab
Source studies (1)Record ID: I-CTG-chemotherapy-plus-bevacizumab-fa81e187f1
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Chest x-ray
Source studies (1)Record ID: I-CTG-chest-x-ray-3fa98eebe0
Not recordedNot recordeddiagnostic-testTERMINATED
Chromoendoscopy
Source studies (1)Record ID: I-CTG-chromoendoscopy-af0875c463
Not recordedNot recordedother-or-unclearWITHDRAWN
Cibisatamab
Source studies (1)Record ID: I-CTG-cibisatamab-7c89498bdb
Not recordedNot recordedother-or-unclearTERMINATED
Cisplatin
Source studies (2)Record ID: I-CTG-cisplatin-8114f85e2a
Not recordedNot recordedother-or-unclearRECRUITING
CJM112
Source studies (1)Record ID: I-CTG-cjm112-5dfdfeda68
Not recordedNot recordedother-or-unclearCOMPLETED
Clostridium butyricum
Source studies (1)Record ID: I-CTG-clostridium-butyricum-c2370b6d03
Not recordedNot recordedother-or-unclearRECRUITING
CM-24 (MK-6018)
Source studies (1)Record ID: I-CTG-cm-24-mk-6018-f0ba3f9e9f
Not recordedNot recordedantibodyTERMINATED
CMAB009
Source studies (1)Record ID: I-CTG-cmab009-ed1299fc41
Not recordedNot recordedother-or-unclearCOMPLETED
CNA3103: 1.5 x 10^8 cells
Source studies (1)Record ID: I-CTG-cna3103-1-5-x-10-8-cells-77927f9de8
Not recordedNot recordedother-or-unclearRECRUITING
CNA3103: 1.5 x 10^9 cells
Source studies (1)Record ID: I-CTG-cna3103-1-5-x-10-9-cells-7b8c8a35bf
Not recordedNot recordedother-or-unclearRECRUITING
CNA3103: 2.5 x 10^7 cells
Source studies (1)Record ID: I-CTG-cna3103-2-5-x-10-7-cells-39766e37d3
Not recordedNot recordedother-or-unclearRECRUITING
CNA3103: 4.5 x 10^8 cells
Source studies (1)Record ID: I-CTG-cna3103-4-5-x-10-8-cells-b238ca48c9
Not recordedNot recordedother-or-unclearRECRUITING
CNA3103: 5 x 10^7 cells
Source studies (1)Record ID: I-CTG-cna3103-5-x-10-7-cells-ed12107ac1
Not recordedNot recordedother-or-unclearRECRUITING
CNA3103: 6.75 × 10^8 cells
Source studies (1)Record ID: I-CTG-cna3103-6-75-10-8-cells-4f68dfa5a1
Not recordedNot recordedother-or-unclearRECRUITING
Cobimetinib
Source studies (1)Record ID: I-CTG-cobimetinib-da77e494cc
Not recordedNot recordedother-or-unclearCOMPLETED
Colectomy
Source studies (1)Record ID: I-CTG-colectomy-8a2d7bf2fb
Not recordedNot recordedprocedure-or-deviceRECRUITING
Colonoscopy
Source studies (1)Record ID: I-CTG-colonoscopy-255c6f3995
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Colonoscopy with Retroview scope combing forward and retroflexed withdrawal technique
Source studies (1)Record ID: I-CTG-colonoscopy-with-retroview-scope-combing-f-e77e031f92
Not recordedNot recordeddiagnostic-testCOMPLETED
Colonoscopy with standard colonoscope and forward withdrawal technique
Source studies (1)Record ID: I-CTG-colonoscopy-with-standard-colonoscope-and--f34c8cebcc
Not recordedNot recordeddiagnostic-testCOMPLETED
Colorectal cancer procedures
Source studies (1)Record ID: I-CTG-colorectal-cancer-procedures-bfa4f087aa
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Colorectal surgery (resection)
Source studies (1)Record ID: I-CTG-colorectal-surgery-resection-805dd62c05
Not recordedNot recordedprocedure-or-deviceCOMPLETED
COM701
Source studies (1)Record ID: I-CTG-com701-eb74d629d9
Not recordedNot recordedother-or-unclearCOMPLETED
COM701 with Opdivo (Nivolumab).
Source studies (1)Record ID: I-CTG-com701-with-opdivo-nivolumab-e3d14f4c17
Not recordedNot recordedother-or-unclearCOMPLETED
Combination Therapy: PY314 + Pembrolizumab
Source studies (1)Record ID: I-CTG-combination-therapy-py314-pembrolizumab-397f9f194b
Not recordedNot recordedother-or-unclearTERMINATED
Computed Tomography
Source studies (17)Record ID: I-CTG-computed-tomography-d4953cd85e
Not recordedNot recordedmolecular-imaging-agentACTIVE_NOT_RECRUITING / ENROLLING_BY_INVITATION / RECRUITING / TERMINATED
Computer-aided diagnosis (CADx) support tool
Source studies (1)Record ID: I-CTG-computer-aided-diagnosis-cadx-support-tool-3c1ea5a6ea
Not recordedNot recordeddiagnostic-testCOMPLETED
Conatumumab
Source studies (1)Record ID: I-CTG-conatumumab-1002c2336a
Not recordedNot recordedother-or-unclearCOMPLETED
Confocal endomicroscopy
Source studies (1)Record ID: I-CTG-confocal-endomicroscopy-6af8f1b27c
Not recordedNot recordedprocedure-or-deviceCOMPLETED
Confocal laser endomicroscopy (CLE)
Source studies (1)Record ID: I-CTG-confocal-laser-endomicroscopy-cle-a7feb51e6c
Not recordedNot recordedprocedure-or-deviceUNKNOWN
Continuous hyperthermic peritoneal perfusion (CHPP) with Cisplatin
Source studies (1)Record ID: I-CTG-continuous-hyperthermic-peritoneal-perfusi-7542d19b4a
Not recordedNot recordedprocedure-or-deviceCOMPLETED
Contrasting CT
Source studies (1)Record ID: I-CTG-contrasting-ct-f6ec36a18e
Not recordedNot recordedradiationUNKNOWN
Control group
Source studies (1)Record ID: I-CTG-control-group-bfb83ec17b
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
conventional surgery
Source studies (1)Record ID: I-CTG-conventional-surgery-983550c6c0
Not recordedNot recordedprocedure-or-deviceCOMPLETED
CP-675,206
Source studies (1)Record ID: I-CTG-cp-675-206-a32de41159
Not recordedNot recordedother-or-unclearCOMPLETED
CPGJ602
Source studies (1)Record ID: I-CTG-cpgj602-8f9c6c2f70
Not recordedNot recordedother-or-unclearUNKNOWN
CPI-006 + ciforadenant
Source studies (1)Record ID: I-CTG-cpi-006-ciforadenant-c153076cc2
Not recordedNot recordedother-or-unclearCOMPLETED
CPI-006 + pembrolizumab
Source studies (1)Record ID: I-CTG-cpi-006-pembrolizumab-3ab6f2ce6c
Not recordedNot recordedother-or-unclearCOMPLETED
Creatinine clearance
Source studies (1)Record ID: I-CTG-creatinine-clearance-18461fe2a0
Not recordedNot recordedother-or-unclearUNKNOWN
Crisaborole Ointment
Source studies (1)Record ID: I-CTG-crisaborole-ointment-f6a3fcb92f
Not recordedNot recordedother-or-unclearUNKNOWN
CT
Source studies (1)Record ID: I-CTG-ct-f8dcb34308
Not recordedNot recordeddiagnostic-testTERMINATED
CT scan
Source studies (1)Record ID: I-CTG-ct-scan-25e54eb278
Not recordedNot recordeddiagnostic-testCOMPLETED
ctDNA methylation dynamic monitoring
Source studies (1)Record ID: I-CTG-ctdna-methylation-dynamic-monitoring-e78a5899f0
Not recordedNot recordeddiagnostic-testRECRUITING
ctDNA Mutation Analysis via ddPCR
Source studies (1)Record ID: I-CTG-ctdna-mutation-analysis-via-ddpcr-158cc851ac
Not recordedNot recordeddiagnostic-testRECRUITING
ctDNA testing
Source studies (1)Record ID: I-CTG-ctdna-testing-188082d0ed
Not recordedNot recordedother-or-unclearRECRUITING
CV301
Source studies (1)Record ID: I-CTG-cv301-53b7453e29
Not recordedNot recordedvaccineCOMPLETED
CYAD-101
Source studies (2)Record ID: I-CTG-cyad-101-869368c463
Not recordedNot recordedcar-t-cell-therapyRECRUITING
Cyclophosphamide
Source studies (10)Record ID: I-CTG-cyclophosphamide-f8f5717419
Not recordedNot recordedother-or-unclearRECRUITING / TERMINATED / WITHDRAWN
DacogenTM (decitabine)
Source studies (1)Record ID: I-CTG-dacogentm-decitabine-1b1d831e14
Not recordedNot recordedother-or-unclearCOMPLETED
Dalotuzumab 10 mg/kg
Source studies (1)Record ID: I-CTG-dalotuzumab-10-mg-kg-73403e9c09
Not recordedNot recordedother-or-unclearCOMPLETED
Dalotuzumab 15/7.5 mg/kg
Source studies (1)Record ID: I-CTG-dalotuzumab-15-7-5-mg-kg-cb2902ab21
Not recordedNot recordedother-or-unclearCOMPLETED
DDI Probe Cocktail
Source studies (1)Record ID: I-CTG-ddi-probe-cocktail-1ab21be774
Not recordedNot recordedother-or-unclearRECRUITING
DEBIRI
Source studies (1)Record ID: I-CTG-debiri-90728d2685
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Decitabine
Source studies (1)Record ID: I-CTG-decitabine-44e1b32827
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
Decoy20
Source studies (1)Record ID: I-CTG-decoy20-942a6c91bd
Not recordedagonistother-or-unclearACTIVE_NOT_RECRUITING
Dendritic Cell Vaccine
Source studies (1)Record ID: I-CTG-dendritic-cell-vaccine-40ced16617
Not recordedNot recordedvaccineCOMPLETED
Dendritic cells vaccine
Source studies (1)Record ID: I-CTG-dendritic-cells-vaccine-e87c5fcd01
Not recordedNot recordedvaccineUNKNOWN
denileukin diftitox
Source studies (1)Record ID: I-CTG-denileukin-diftitox-1d79e88212
Not recordedNot recordedother-or-unclearCOMPLETED
Digital Rectal Examination
Source studies (1)Record ID: I-CTG-digital-rectal-examination-382bc63c95
Not recordedNot recordedprocedure-or-deviceRECRUITING
Diphenhydramine hydrochloride (HCl)
Source studies (1)Record ID: I-CTG-diphenhydramine-hydrochloride-hcl-c1cd720f4e
Not recordedNot recordedother-or-unclearTERMINATED
Diphtheria/Tetanus Vaccine
Source studies (1)Record ID: I-CTG-diphtheria-tetanus-vaccine-155e5d9925
Not recordedNot recordedvaccineTERMINATED
DISP-10
Source studies (1)Record ID: I-CTG-disp-10-89d47f9270
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
Divarasib
Source studies (1)Record ID: I-CTG-divarasib-396157f6b6
Not recordedNot recordedother-or-unclearRECRUITING
Docetaxel
Source studies (3)Record ID: I-CTG-docetaxel-1ad915ad9e
Not recordedNot recordedother-or-unclearCOMPLETED / RECRUITING
Docetaxel (Taxotere)
Source studies (1)Record ID: I-CTG-docetaxel-taxotere-168b0a7cb0
Not recordedNot recordedother-or-unclearRECRUITING
Dostarlimab
Source studies (1)Record ID: I-CTG-dostarlimab-b72c71f530
Not recordedNot recordedantibodyCOMPLETED
DS-8201a
Source studies (1)Record ID: I-CTG-ds-8201a-cf25a7a751
Not recordedNot recordedother-or-unclearCOMPLETED
DS-8201a 5.4 mg/kg Q3W
Source studies (1)Record ID: I-CTG-ds-8201a-5-4-mg-kg-q3w-e5805da10c
Not recordedNot recordedother-or-unclearCOMPLETED
DS-8201a 6.4 mg/kg Q3W
Source studies (1)Record ID: I-CTG-ds-8201a-6-4-mg-kg-q3w-df2034b62f
Not recordedNot recordedother-or-unclearCOMPLETED
Dual-Target Antigen-Selected CAR-NK
Source studies (1)Record ID: I-CTG-dual-target-antigen-selected-car-nk-c69960a6a1
Not recordedNot recordedcar-nk-cell-therapyRECRUITING
Dye-Based Chromoendoscopy
Source studies (1)Record ID: I-CTG-dye-based-chromoendoscopy-dd57846283
Not recordedNot recordedprocedure-or-deviceNOT_YET_RECRUITING
E7 TCR-T cells
Source studies (2)Record ID: I-CTG-e7-tcr-t-cells-28141aa90b
Not recordedNot recordedcellular-therapyRECRUITING
E7046
Source studies (1)Record ID: I-CTG-e7046-9a933e04a4
Not recordedNot recordedother-or-unclearCOMPLETED
EB-SELECT Single-Target CAR-NK Cells
Source studies (1)Record ID: I-CTG-eb-select-single-target-car-nk-cells-f1020c8ad8
Not recordedNot recordedcar-nk-cell-therapyRECRUITING
Echocardiography Test
Source studies (3)Record ID: I-CTG-echocardiography-test-b5bb6dc083
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING / RECRUITING
Educational Intervention
Source studies (1)Record ID: I-CTG-educational-intervention-90963afc6d
Not recordedNot recordedother-or-unclearRECRUITING
EGF816
Source studies (1)Record ID: I-CTG-egf816-65942cfc88
Not recordedNot recordedother-or-unclearCOMPLETED
EKG
Source studies (1)Record ID: I-CTG-ekg-1518c8fdc6
Not recordedNot recordeddiagnostic-testTERMINATED
Electronic Health Record Review
Source studies (2)Record ID: I-CTG-electronic-health-record-review-58bf833df3
Not recordedNot recordedother-or-unclearRECRUITING
ELI-002 7P
Source studies (1)Record ID: I-CTG-eli-002-7p-1fc1f11779
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Emavusertib
Source studies (1)Record ID: I-CTG-emavusertib-198f10d92d
Not recordedNot recordedother-or-unclearRECRUITING
EMB-01
Source studies (1)Record ID: I-CTG-emb-01-c55ad0eb9b
Not recordedNot recordedbispecific-antibodyNOT_YET_RECRUITING
EMI-137
Source studies (1)Record ID: I-CTG-emi-137-5c73a8f0cd
Not recordedNot recordedother-or-unclearCOMPLETED
encorafenib
Source studies (1)Record ID: I-CTG-encorafenib-66cf055d05
Not recordedNot recordedother-or-unclearTERMINATED
endocytoscopy
Source studies (1)Record ID: I-CTG-endocytoscopy-a0b76fa672
Not recordedNot recordeddiagnostic-testCOMPLETED
Endoscope
Source studies (1)Record ID: I-CTG-endoscope-8590d2a265
Not recordedNot recordedprocedure-or-deviceRECRUITING
Endoscopic Procedure
Source studies (1)Record ID: I-CTG-endoscopic-procedure-8af6485519
Not recordedNot recordedprocedure-or-deviceRECRUITING
Endoscopy
Source studies (1)Record ID: I-CTG-endoscopy-14a417830e
Not recordedNot recordedother-or-unclearUNKNOWN
Enzalutamide
Source studies (3)Record ID: I-CTG-enzalutamide-02d130d71a
Not recordedNot recordedother-or-unclearCOMPLETED / RECRUITING / TERMINATED
EO2040
Source studies (1)Record ID: I-CTG-eo2040-1f62e48b14
Not recordedNot recordedvaccineTERMINATED
epidural
Source studies (1)Record ID: I-CTG-epidural-864413e5bb
Not recordedNot recordedprocedure-or-deviceUNKNOWN
Erlotinib
Source studies (1)Record ID: I-CTG-erlotinib-fa6bba6f28
Not recordedNot recordedother-or-unclearUNKNOWN
erlotinib hydrochloride
Source studies (2)Record ID: I-CTG-erlotinib-hydrochloride-25091918cd
Not recordedNot recordedother-or-unclearCOMPLETED
ETBX-011
Source studies (1)Record ID: I-CTG-etbx-011-51ede04218
Not recordedNot recordedvaccineWITHDRAWN
ETBX-021
Source studies (1)Record ID: I-CTG-etbx-021-adeeb90c9f
Not recordedNot recordedvaccineWITHDRAWN
ETBX-051
Source studies (1)Record ID: I-CTG-etbx-051-c8adc785a4
Not recordedNot recordedvaccineWITHDRAWN
ETBX-061
Source studies (1)Record ID: I-CTG-etbx-061-20b1a51bf2
Not recordedNot recordedvaccineWITHDRAWN
Experimental Group
Source studies (1)Record ID: I-CTG-experimental-group-ee3e8ab9d9
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
Experimental: COLONYVAQ-CRC + mFOLFOX6 or CAPOX + Nivolumab
Source studies (1)Record ID: I-CTG-experimental-colonyvaq-crc-mfolfox6-or-cap-5487896cc8
Not recordedNot recordedvaccineRECRUITING
Extension HER-2 vaccine trial at OBD
Source studies (1)Record ID: I-CTG-extension-her-2-vaccine-trial-at-obd-755266448d
Not recordedNot recordedvaccineCOMPLETED
F-18 16 Alpha-Fluoroestradiol
Source studies (1)Record ID: I-CTG-f-18-16-alpha-fluoroestradiol-131fc1e46a
Not recordedNot recordedmolecular-imaging-agentTERMINATED
Faecal Immunochemical Test
Source studies (1)Record ID: I-CTG-faecal-immunochemical-test-5870f968de
Not recordedNot recordeddiagnostic-testUNKNOWN
Fam-Trastuzumab Deruxtecan-Nxki
Source studies (1)Record ID: I-CTG-fam-trastuzumab-deruxtecan-nxki-f9be2eb3a8
Not recordedNot recordedother-or-unclearRECRUITING
FATE-NK100
Source studies (1)Record ID: I-CTG-fate-nk100-41bd5322f7
Not recordedNot recordedcellular-therapyCOMPLETED
Flow cytometry
Source studies (1)Record ID: I-CTG-flow-cytometry-0e267cdbea
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
FLOX (5-fluorouracil and folinic acid and oxaliplatin) intermittently and maintenance cetuximab
Source studies (1)Record ID: I-CTG-flox-5-fluorouracil-and-folinic-acid-and-o-3b6c9dadca
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
FLOX (5-fluorouracil/folinic acid/oxaliplatin)
Source studies (1)Record ID: I-CTG-flox-5-fluorouracil-folinic-acid-oxaliplat-d728562dd9
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
FLOX (5-fluorouracil/folinic acid/oxaliplatin) and Cetuximab
Source studies (1)Record ID: I-CTG-flox-5-fluorouracil-folinic-acid-oxaliplat-a4c08af5e7
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Fludarabine
Source studies (6)Record ID: I-CTG-fludarabine-cb9905f3e0
Not recordedNot recordedother-or-unclearRECRUITING / TERMINATED
Fluorescence-Guided Surgery
Source studies (1)Record ID: I-CTG-fluorescence-guided-surgery-00a8f26f44
Not recordedNot recordedprocedure-or-deviceRECRUITING
Fluoropyrimidine (5-FU/LV or capecitabine)
Source studies (1)Record ID: I-CTG-fluoropyrimidine-5-fu-lv-or-capecitabine-d8b0b970a1
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
fluorouracil
Source studies (15)Record ID: I-CTG-fluorouracil-9095bd0841
Not recordedNot recordedconventional-cytotoxic-regimenACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED / UNKNOWN
Fluorouracil (5-FU)
Source studies (1)Record ID: I-CTG-fluorouracil-5-fu-e06666de0c
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
FOLFIRI
Source studies (12)Record ID: I-CTG-folfiri-35fc3df147
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED / NOT_YET_RECRUITING / RECRUITING / TERMINATED
FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)
Source studies (1)Record ID: I-CTG-folfiri-5-fluorouracil-folinic-acid-irinot-2b114c7db7
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
FOLFIRI + Cetuximab
Source studies (2)Record ID: I-CTG-folfiri-cetuximab-860059a0ea
Not recordedNot recordedantibodyUNKNOWN
FOLFIRI Protocol
Source studies (3)Record ID: I-CTG-folfiri-protocol-7d8f4e05f8
Not recordedNot recordedconventional-cytotoxic-regimenACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING
FOLFIRI regimen
Source studies (1)Record ID: I-CTG-folfiri-regimen-c607e2b8f0
Not recordedNot recordedconventional-cytotoxic-regimenTERMINATED
Folfiri/Cetuximab
Source studies (1)Record ID: I-CTG-folfiri-cetuximab-4796e99102
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
FOLFOX
Source studies (3)Record ID: I-CTG-folfox-d34f6ef74e
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
FOLFOX 6
Source studies (1)Record ID: I-CTG-folfox-6-e0fad68f21
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
FOLFOX induction regimen
Source studies (1)Record ID: I-CTG-folfox-induction-regimen-9bade73465
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
FOLFOX regimen
Source studies (4)Record ID: I-CTG-folfox-regimen-ea3401d06d
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED / TERMINATED / UNKNOWN
FOLFOX-4
Source studies (1)Record ID: I-CTG-folfox-4-d040833f0b
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
FOLFOXIRI plus Bevacizumab
Source studies (1)Record ID: I-CTG-folfoxiri-plus-bevacizumab-364286467b
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Folic acid
Source studies (2)Record ID: I-CTG-folic-acid-501412629a
Not recordedNot recordedother-or-unclearUNKNOWN
Folinic acid
Source studies (4)Record ID: I-CTG-folinic-acid-555688dff7
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED / RECRUITING / UNKNOWN
folinic acid/5-FU/oxaliplatin (mFOLFOX-6)
Source studies (1)Record ID: I-CTG-folinic-acid-5-fu-oxaliplatin-mfolfox-6-f63a4d8e1f
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
FoundationOne®Liquid CDx
Source studies (1)Record ID: I-CTG-foundationoneliquid-cdx-f5f2d66cf0
Not recordedNot recordeddiagnostic-testRECRUITING
FPI-2053
Source studies (1)Record ID: I-CTG-fpi-2053-a6fb70a89b
Not recordedNot recordedbispecific-antibodyACTIVE_NOT_RECRUITING
FT536
Source studies (1)Record ID: I-CTG-ft536-68cc3bb06f
Not recordedNot recordedother-or-unclearTERMINATED
fulvestrant
Source studies (3)Record ID: I-CTG-fulvestrant-45c4801d03
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING / RECRUITING / WITHDRAWN
Futuximab
Source studies (1)Record ID: I-CTG-futuximab-083f8ace97
Not recordedNot recordedantibodyTERMINATED
G17DT-Irinotecan
Source studies (1)Record ID: I-CTG-g17dt-irinotecan-112db7bbf1
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Ga-68-FAPI-46
Source studies (1)Record ID: I-CTG-ga-68-fapi-46-53a9f71020
Not recordedNot recordedother-or-unclearRECRUITING
Gallium Ga 68 FAPi-46
Source studies (1)Record ID: I-CTG-gallium-ga-68-fapi-46-15339208a2
Not recordedNot recordedradiationACTIVE_NOT_RECRUITING
Gallium Ga 68-labeled PSMA-11
Source studies (1)Record ID: I-CTG-gallium-ga-68-labeled-psma-11-9bb7e663d2
Not recordedNot recordedradiationACTIVE_NOT_RECRUITING
Gamma-Secretase Inhibitor RO4929097
Source studies (1)Record ID: I-CTG-gamma-secretase-inhibitor-ro4929097-1775af3aa6
Not recordedinhibitorother-or-unclearTERMINATED
Gardasil
Source studies (1)Record ID: I-CTG-gardasil-16ee4fb02f
Not recordedNot recordedother-or-unclearUNKNOWN
Gemcitabine
Source studies (3)Record ID: I-CTG-gemcitabine-cb0f740757
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING / UNKNOWN
Gemcitabine + Nab-paclitaxel
Source studies (1)Record ID: I-CTG-gemcitabine-nab-paclitaxel-7dd4208c30
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
Gene Modified T Cells
Source studies (2)Record ID: I-CTG-gene-modified-t-cells-fc791108b3
Not recordedNot recordedcellular-therapySUSPENDED / TERMINATED
GI-4000
Source studies (1)Record ID: I-CTG-gi-4000-8114732f91
Not recordedNot recordedvaccineWITHDRAWN
GI-6207
Source studies (1)Record ID: I-CTG-gi-6207-a3bf2bdcf9
Not recordedNot recordedvaccineWITHDRAWN
GI-6301
Source studies (1)Record ID: I-CTG-gi-6301-7ace324b92
Not recordedNot recordedvaccineWITHDRAWN
Glycosylated Recombinant Human Interleukin-7
Source studies (1)Record ID: I-CTG-glycosylated-recombinant-human-interleukin-22e6df37bf
Not recordedNot recordedother-or-unclearTERMINATED
GM-CT-01 plus 5-Fluorouracil
Source studies (1)Record ID: I-CTG-gm-ct-01-plus-5-fluorouracil-d4bb5b655a
Not recordedNot recordedconventional-cytotoxic-regimenTERMINATED
GM102
Source studies (1)Record ID: I-CTG-gm102-28e316180e
Not recordedNot recordedother-or-unclearCOMPLETED
GM102 expansion
Source studies (1)Record ID: I-CTG-gm102-expansion-a5fb9bace4
Not recordedNot recordedother-or-unclearCOMPLETED
GSK5764227
Source studies (1)Record ID: I-CTG-gsk5764227-624456bca2
Not recordedNot recordedother-or-unclearRECRUITING
haNK
Source studies (1)Record ID: I-CTG-hank-0a99b793f4
Not recordedNot recordedother-or-unclearWITHDRAWN
HBs antibody and HBc antibody
Source studies (1)Record ID: I-CTG-hbs-antibody-and-hbc-antibody-f4b0725ed8
Not recordedNot recordedantibodyUNKNOWN
HBs antigen and HCV antibody
Source studies (1)Record ID: I-CTG-hbs-antigen-and-hcv-antibody-c0e3aee1da
Not recordedNot recordedantibodyUNKNOWN
HD Colon
Source studies (2)Record ID: I-CTG-hd-colon-d1daf5e764
Not recordedNot recordedprocedure-or-deviceCOMPLETED / UNKNOWN
Hepatitis A Vaccine
Source studies (1)Record ID: I-CTG-hepatitis-a-vaccine-9cc9cd5d2c
Not recordedNot recordedvaccineTERMINATED
Hepatitis B Vaccine
Source studies (1)Record ID: I-CTG-hepatitis-b-vaccine-04776562f0
Not recordedNot recordedvaccineTERMINATED
HER-2 vaccine
Source studies (1)Record ID: I-CTG-her-2-vaccine-0f2c831000
Not recordedNot recordedvaccineCOMPLETED
High definition white light endoscopy
Source studies (1)Record ID: I-CTG-high-definition-white-light-endoscopy-6d4580e861
Not recordedNot recordedother-or-unclearWITHDRAWN
High Definition White Light Endosocopy
Source studies (1)Record ID: I-CTG-high-definition-white-light-endosocopy-14d56656d6
Not recordedNot recordedother-or-unclearWITHDRAWN
HIPEC
Source studies (1)Record ID: I-CTG-hipec-cefb483ae4
Not recordedNot recordedprocedure-or-deviceCOMPLETED
HMBD-001
Source studies (1)Record ID: I-CTG-hmbd-001-a5fb342724
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
HMBD-001 and enzalutamide
Source studies (1)Record ID: I-CTG-hmbd-001-and-enzalutamide-acde4f5f43
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
huA33
Source studies (1)Record ID: I-CTG-hua33-7320a578ae
Not recordedNot recordedother-or-unclearCOMPLETED
Huaier granule
Source studies (1)Record ID: I-CTG-huaier-granule-22f248c6e6
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
HuC242-DM4
Source studies (1)Record ID: I-CTG-huc242-dm4-fbf428acab
Not recordedNot recordedother-or-unclearCOMPLETED
I-Scan 1
Source studies (2)Record ID: I-CTG-i-scan-1-767b38fc5b
Not recordedNot recordedprocedure-or-deviceCOMPLETED / UNKNOWN
I-Scan 2
Source studies (2)Record ID: I-CTG-i-scan-2-85eb2b3764
Not recordedNot recordedprocedure-or-deviceCOMPLETED / UNKNOWN
i-scan CE, SE, TE mode
Source studies (1)Record ID: I-CTG-i-scan-ce-se-te-mode-64102b4db8
Not recordedNot recordedprocedure-or-deviceCOMPLETED
ICG
Source studies (1)Record ID: I-CTG-icg-183a746658
Not recordedNot recordedother-or-unclearCOMPLETED
IKS04 antibody drug conjugate ADC + Isumab04 monoclonal antibody
Source studies (1)Record ID: I-CTG-iks04-antibody-drug-conjugate-adc-isumab04-99f7e1dc77
Not recordedcytotoxic-payload-deliveryantibody-drug-conjugateNOT_YET_RECRUITING
IL-2
Source studies (2)Record ID: I-CTG-il-2-2f861543e7
Not recordedNot recordedantibodySUSPENDED / TERMINATED
IL2
Source studies (1)Record ID: I-CTG-il2-839489f4fd
Not recordedNot recordedvaccineRECRUITING
Imaging study
Source studies (1)Record ID: I-CTG-imaging-study-ce73d4d01a
Not recordedNot recordedother-or-unclearTERMINATED
Imaging Technique
Source studies (1)Record ID: I-CTG-imaging-technique-b81c2ffbd9
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Imatinib mesylate and panitumumab
Source studies (1)Record ID: I-CTG-imatinib-mesylate-and-panitumumab-19db40f9ca
Not recordedNot recordedother-or-unclearCOMPLETED
IMC-A12
Source studies (1)Record ID: I-CTG-imc-a12-68ed666b05
Not recordedNot recordedother-or-unclearCOMPLETED
IMC-A12 (cixutumumab)
Source studies (1)Record ID: I-CTG-imc-a12-cixutumumab-14d748b189
Not recordedNot recordedother-or-unclearTERMINATED
Imiquimod
Source studies (1)Record ID: I-CTG-imiquimod-ab6fc72dae
Not recordedNot recordedother-or-unclearENROLLING_BY_INVITATION
Immunohistochemistry
Source studies (1)Record ID: I-CTG-immunohistochemistry-e5a00a7d8d
Not recordedNot recordeddiagnostic-testCOMPLETED
Immunohistochemistry or immunofluorescence
Source studies (1)Record ID: I-CTG-immunohistochemistry-or-immunofluorescence-4e7605b331
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
Immunotherapeutic Agents
Source studies (1)Record ID: I-CTG-immunotherapeutic-agents-d86db01d18
Not recordedNot recordedother-or-unclearCOMPLETED
Immunotherapy
Source studies (2)Record ID: I-CTG-immunotherapy-f3bf3779cf
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING / RECRUITING
IMO-2055
Source studies (1)Record ID: I-CTG-imo-2055-35cf7400a8
Not recordedNot recordedother-or-unclearTERMINATED
Impact of Gender on Davinci rectal surgery
Source studies (1)Record ID: I-CTG-impact-of-gender-on-davinci-rectal-surgery-4282ba07bc
Not recordedNot recordedprocedure-or-deviceCOMPLETED
IMT-009
Source studies (1)Record ID: I-CTG-imt-009-1ad49d3434
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Inavolisib
Source studies (1)Record ID: I-CTG-inavolisib-3eae227893
Not recordedNot recordedother-or-unclearRECRUITING
INCAGN01876
Source studies (1)Record ID: I-CTG-incagn01876-21ea5e3fa0
Not recordedNot recordedother-or-unclearCOMPLETED
Indium labeled IMP-205xm734
Source studies (1)Record ID: I-CTG-indium-labeled-imp-205xm734-fdb1ad65c0
Not recordedNot recordedother-or-unclearCOMPLETED
INT230-6
Source studies (1)Record ID: I-CTG-int230-6-3bc32b436c
Not recordedNot recordedother-or-unclearCOMPLETED
Interleukin-2
Source studies (1)Record ID: I-CTG-interleukin-2-531a829bc6
Not recordedNot recordedother-or-unclearRECRUITING
Internet-Based Intervention
Source studies (1)Record ID: I-CTG-internet-based-intervention-a8c0566a46
Not recordedNot recordedother-or-unclearRECRUITING
Iodine I 124 Monoclonal Antibody M5A
Source studies (1)Record ID: I-CTG-iodine-i-124-monoclonal-antibody-m5a-3d0b190b93
Not recordedNot recordedmolecular-imaging-agentCOMPLETED
Irinotecan
Source studies (20)Record ID: I-CTG-irinotecan-3298e18a64
Not recordedNot recordedconventional-cytotoxic-regimenACTIVE_NOT_RECRUITING / COMPLETED / NOT_YET_RECRUITING / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN
Irinotecan (Camptosar)
Source studies (1)Record ID: I-CTG-irinotecan-camptosar-ed020bb67e
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
irinotecan hydrochloride
Source studies (7)Record ID: I-CTG-irinotecan-hydrochloride-cd73034bfe
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED / TERMINATED
Itraconazole
Source studies (1)Record ID: I-CTG-itraconazole-25098b221a
Not recordedNot recordedother-or-unclearRECRUITING
IX001 TCR-T cells
Source studies (1)Record ID: I-CTG-ix001-tcr-t-cells-520199426c
Not recordedNot recordedcellular-therapyWITHDRAWN
JAB-3312
Source studies (2)Record ID: I-CTG-jab-3312-c22867e75e
Not recordedNot recordedother-or-unclearCOMPLETED
JNJ-78306358
Source studies (1)Record ID: I-CTG-jnj-78306358-208bd1f312
Not recordedNot recordedother-or-unclearCOMPLETED
KL-140
Source studies (1)Record ID: I-CTG-kl-140-f567d37d02
Not recordedNot recordedconventional-cytotoxic-regimenTERMINATED
KRAS BRAF mutant Sintilimab + regafinil
Source studies (1)Record ID: I-CTG-kras-braf-mutant-sintilimab-regafinil-1470da0aa8
Not recordedNot recordedother-or-unclearUNKNOWN
l-LV
Source studies (1)Record ID: I-CTG-l-lv-732e59f83b
Not recordedNot recordedother-or-unclearUNKNOWN
L-OHP (130mg/m2)
Source studies (1)Record ID: I-CTG-l-ohp-130mg-m2-eefa83ccf2
Not recordedNot recordedother-or-unclearUNKNOWN
L-OHP (85 mg/m2)
Source studies (1)Record ID: I-CTG-l-ohp-85-mg-m2-4da8ea34dd
Not recordedNot recordedother-or-unclearUNKNOWN
Labetuzumab Govitecan (LG)
Source studies (1)Record ID: I-CTG-labetuzumab-govitecan-lg-76b9d44000
Not recordedNot recordedother-or-unclearTERMINATED
Laboratory Biomarker Analysis
Source studies (13)Record ID: I-CTG-laboratory-biomarker-analysis-5dff388dd6
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING / COMPLETED / TERMINATED
Laboratory test
Source studies (1)Record ID: I-CTG-laboratory-test-905b6fc4d1
Not recordedNot recordedother-or-unclearUNKNOWN
LB-100
Source studies (1)Record ID: I-CTG-lb-100-99b29ca4a0
Not recordedNot recordedother-or-unclearRECRUITING
LC Bead M1
Source studies (1)Record ID: I-CTG-lc-bead-m1-cae64da0e3
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Lenalidomide
Source studies (1)Record ID: I-CTG-lenalidomide-5f0194b3aa
Not recordedNot recordedother-or-unclearCOMPLETED
Lenvatinib
Source studies (1)Record ID: I-CTG-lenvatinib-949cb28155
Not recordedNot recordedother-or-unclearCOMPLETED
leucovorin
Source studies (11)Record ID: I-CTG-leucovorin-477cf9e8e1
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN
Leucovorin Calcium
Source studies (6)Record ID: I-CTG-leucovorin-calcium-12cd7dfb0d
Not recordedNot recordedother-or-unclearCOMPLETED / RECRUITING / TERMINATED
LGX818
Source studies (1)Record ID: I-CTG-lgx818-7201f7370f
Not recordedNot recordedother-or-unclearCOMPLETED
Lomotil
Source studies (1)Record ID: I-CTG-lomotil-2f49e64322
Not recordedNot recordedother-or-unclearCOMPLETED
Long Course Chemoradiotherapy (LCRT)
Source studies (1)Record ID: I-CTG-long-course-chemoradiotherapy-lcrt-8ef4c30b58
Not recordedNot recordedradiationCOMPLETED
Long Range NGS HLA typing
Source studies (1)Record ID: I-CTG-long-range-ngs-hla-typing-81c163d1b8
Not recordedNot recordeddiagnostic-testRECRUITING
Lorigerlimab
Source studies (1)Record ID: I-CTG-lorigerlimab-bce46b3b96
Not recordedNot recordedbispecific-antibodyCOMPLETED
lorlatinib
Source studies (1)Record ID: I-CTG-lorlatinib-dd395f4ea5
Not recordedNot recordedother-or-unclearTERMINATED
Lovaza
Source studies (1)Record ID: I-CTG-lovaza-27b865bab7
Not recordedNot recordedother-or-unclearWITHDRAWN
Low dose [177Lu]Lu-A9-0631
Source studies (1)Record ID: I-CTG-low-dose-177lu-lu-a9-0631-59fb059ef2
Not recordedNot recordedradioligand-therapyRECRUITING
LY2157299
Source studies (1)Record ID: I-CTG-ly2157299-6d0eb5d7f4
Not recordedNot recordedsmall-moleculeACTIVE_NOT_RECRUITING
LY4257496
Source studies (1)Record ID: I-CTG-ly4257496-f47e0b6be4
Not recordedNot recordedother-or-unclearRECRUITING
LY4257529
Source studies (1)Record ID: I-CTG-ly4257529-a6560d255b
Not recordedNot recordeddiagnostic-testRECRUITING
Lycopene
Source studies (1)Record ID: I-CTG-lycopene-8fe10f92e2
Not recordedNot recordedother-or-unclearUNKNOWN
LYL273
Source studies (1)Record ID: I-CTG-lyl273-4b65a0f719
Not recordedNot recordedcar-t-cell-therapyRECRUITING
Lymphodepletion
Source studies (1)Record ID: I-CTG-lymphodepletion-d9aa4bb4f0
Not recordedNot recordedcar-nk-cell-therapyRECRUITING
m-FOLFOX-6 regimen
Source studies (1)Record ID: I-CTG-m-folfox-6-regimen-e461ed5c58
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Magnesium glycinate
Source studies (1)Record ID: I-CTG-magnesium-glycinate-357334ce51
Not recordedNot recordedother-or-unclearCOMPLETED
Magnesium-rich mineral water (Rozana)
Source studies (1)Record ID: I-CTG-magnesium-rich-mineral-water-rozana-b593c89603
Not recordedNot recordedother-or-unclearUNKNOWN
Magnetic Resonance Elastography
Source studies (1)Record ID: I-CTG-magnetic-resonance-elastography-c2f988514f
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Magnetic Resonance Imaging
Source studies (11)Record ID: I-CTG-magnetic-resonance-imaging-8db75186a3
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING / ENROLLING_BY_INVITATION / RECRUITING
magnetic resonance imaging with positron emission tomography scanning
Source studies (1)Record ID: I-CTG-magnetic-resonance-imaging-with-positron-e-a3601d6508
Not recordedNot recordedprocedure-or-deviceTERMINATED
Mammogram
Source studies (1)Record ID: I-CTG-mammogram-670591afa3
Not recordedNot recordeddiagnostic-testUNKNOWN
MCLA-129
Source studies (1)Record ID: I-CTG-mcla-129-5e5c8330bb
Not recordedNot recordedbispecific-antibodyACTIVE_NOT_RECRUITING
MDX-1106
Source studies (1)Record ID: I-CTG-mdx-1106-4f4f9f6015
Not recordedNot recordedother-or-unclearCOMPLETED
MDX2001
Source studies (1)Record ID: I-CTG-mdx2001-28c05f2fd6
Not recordedNot recordedother-or-unclearRECRUITING
Medical Chart Review
Source studies (1)Record ID: I-CTG-medical-chart-review-5ba239bed0
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Medical history and physical examination
Source studies (1)Record ID: I-CTG-medical-history-and-physical-examination-a10d3d3eb0
Not recordedNot recordedother-or-unclearUNKNOWN
MelCancerVac
Source studies (1)Record ID: I-CTG-melcancervac-62927713d3
Not recordedNot recordedother-or-unclearCOMPLETED
Metformin
Source studies (1)Record ID: I-CTG-metformin-c18f8cceb7
Not recordedNot recordedother-or-unclearCOMPLETED
Metoclopramide
Source studies (1)Record ID: I-CTG-metoclopramide-8ddbc3c706
Not recordedNot recordedother-or-unclearCOMPLETED
Metronidazole
Source studies (2)Record ID: I-CTG-metronidazole-524a0b3040
Not recordedNot recordedother-or-unclearUNKNOWN
mFOLFOX6
Source studies (5)Record ID: I-CTG-mfolfox6-4bcab81a9c
Not recordedNot recordedconventional-cytotoxic-regimenACTIVE_NOT_RECRUITING / COMPLETED / NOT_YET_RECRUITING
mitomycin C
Source studies (1)Record ID: I-CTG-mitomycin-c-1fbfe1c12b
Not recordedNot recordedother-or-unclearTERMINATED
MK-0646
Source studies (1)Record ID: I-CTG-mk-0646-4fd2f3ddeb
Not recordedNot recordedconventional-cytotoxic-regimenWITHDRAWN
MK-1697
Source studies (1)Record ID: I-CTG-mk-1697-c2f0cfd65b
Not recordedNot recordedother-or-unclearTERMINATED
Modified FOLFOX
Source studies (1)Record ID: I-CTG-modified-folfox-8e88d4b748
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Modified FOLFOX6
Source studies (1)Record ID: I-CTG-modified-folfox6-c371e07b89
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Modified Vaccinia Virus Ankara Vaccine Expressing p53
Source studies (1)Record ID: I-CTG-modified-vaccinia-virus-ankara-vaccine-exp-01c7ba8124
Not recordedNot recordedvaccineACTIVE_NOT_RECRUITING
Modotuximab
Source studies (1)Record ID: I-CTG-modotuximab-e59aed6c41
Not recordedNot recordedantibodyTERMINATED
Monalizumab
Source studies (1)Record ID: I-CTG-monalizumab-b20b5f3a0f
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Monalizumab/MEDI5257
Source studies (1)Record ID: I-CTG-monalizumab-medi5257-aa7dcbff79
Not recordedNot recordedother-or-unclearWITHDRAWN
MRI
Source studies (1)Record ID: I-CTG-mri-86b3733153
Not recordedNot recordeddiagnostic-testTERMINATED
MRI scan
Source studies (1)Record ID: I-CTG-mri-scan-8b04e2b9bb
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
MSB0011359C
Source studies (1)Record ID: I-CTG-msb0011359c-a7e415b949
Not recordedNot recordedother-or-unclearCOMPLETED
MT-304
Source studies (1)Record ID: I-CTG-mt-304-191b938129
Not recordedNot recordedother-or-unclearRECRUITING
MT-304 + Nivolumab
Source studies (1)Record ID: I-CTG-mt-304-nivolumab-6d974fa050
Not recordedNot recordedother-or-unclearRECRUITING
Multi-mode tumor treatment system
Source studies (2)Record ID: I-CTG-multi-mode-tumor-treatment-system-db11679dc4
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING / RECRUITING
Multigated Acquisition Scan
Source studies (1)Record ID: I-CTG-multigated-acquisition-scan-9e1daf79ee
Not recordedNot recordedprocedure-or-deviceRECRUITING
Multimodal Deep Learning Model Analysis
Source studies (1)Record ID: I-CTG-multimodal-deep-learning-model-analysis-86746ee930
Not recordedNot recordedother-or-unclearRECRUITING
MVT-5873
Source studies (1)Record ID: I-CTG-mvt-5873-fbf4e8bac1
Not recordedNot recordedother-or-unclearCOMPLETED
N-803
Source studies (1)Record ID: I-CTG-n-803-891d9321ab
Not recordedNot recordedother-or-unclearCOMPLETED
nab paclitaxel
Source studies (1)Record ID: I-CTG-nab-paclitaxel-78f836ff99
Not recordedNot recordedother-or-unclearWITHDRAWN
nab-Paclitaxel
Source studies (1)Record ID: I-CTG-nab-paclitaxel-876379c6c9
Not recordedNot recordedother-or-unclearRECRUITING
Nanrilkefusp alfa
Source studies (2)Record ID: I-CTG-nanrilkefusp-alfa-b7922c4227
Not recordedNot recordedother-or-unclearTERMINATED
Narrow band imaging
Source studies (1)Record ID: I-CTG-narrow-band-imaging-5c2930fe9c
Not recordedNot recordedprocedure-or-deviceWITHDRAWN
Natural Killer (NK) Cells
Source studies (1)Record ID: I-CTG-natural-killer-nk-cells-025ec9bc0f
Not recordedNot recordedother-or-unclearCOMPLETED
NBI Function
Source studies (2)Record ID: I-CTG-nbi-function-4db99cb116
Not recordedNot recordedprocedure-or-deviceCOMPLETED / UNKNOWN
NEO212 Oral Capsule
Source studies (1)Record ID: I-CTG-neo212-oral-capsule-cedf19c5ce
Not recordedNot recordedother-or-unclearRECRUITING
neoadjuvant therapy
Source studies (1)Record ID: I-CTG-neoadjuvant-therapy-49585eb21a
Not recordedNot recordedprocedure-or-deviceCOMPLETED
NeoTCR-P1 adoptive cell therapy
Source studies (1)Record ID: I-CTG-neotcr-p1-adoptive-cell-therapy-7c65a49604
Not recordedNot recordedcellular-therapySUSPENDED
Nexavar
Source studies (1)Record ID: I-CTG-nexavar-22e25f1d4c
Not recordedNot recordedother-or-unclearTERMINATED
Next Generation Sequencing (NGS)
Source studies (1)Record ID: I-CTG-next-generation-sequencing-ngs-fe6f9c3d40
Not recordedNot recordeddiagnostic-testRECRUITING
NHS-IL12
Source studies (1)Record ID: I-CTG-nhs-il12-c6e5b8268b
Not recordedNot recordedother-or-unclearCOMPLETED
Nimotuzumab and chemotherapy
Source studies (1)Record ID: I-CTG-nimotuzumab-and-chemotherapy-70271ffbe9
Not recordedNot recordedconventional-cytotoxic-regimenUNKNOWN
Nintedanib
Source studies (1)Record ID: I-CTG-nintedanib-45ffbcd092
Not recordedNot recordedother-or-unclearCOMPLETED
Nivolumab + Relatlimab
Source studies (1)Record ID: I-CTG-nivolumab-relatlimab-c697e48401
Not recordedNot recordedother-or-unclearRECRUITING
NK Cells
Source studies (1)Record ID: I-CTG-nk-cells-0545a45d30
Not recordedNot recordedcellular-therapyRECRUITING
Nogapendekin Alfa
Source studies (1)Record ID: I-CTG-nogapendekin-alfa-ebbb83472c
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Non interventional study
Source studies (1)Record ID: I-CTG-non-interventional-study-32c67f44dd
Not recordedNot recordedother-or-unclearCOMPLETED
non-ICG
Source studies (1)Record ID: I-CTG-non-icg-1c4db64104
Not recordedNot recordedother-or-unclearCOMPLETED
NPC-1C/NEO-102
Source studies (1)Record ID: I-CTG-npc-1c-neo-102-6e847a3366
Not recordedNot recordedother-or-unclearCOMPLETED
NPX267
Source studies (1)Record ID: I-CTG-npx267-9503d7abf9
Not recordedNot recordedother-or-unclearSUSPENDED
NV1020
Source studies (1)Record ID: I-CTG-nv1020-10d6ab1e16
Not recordedNot recordedother-or-unclearCOMPLETED
OB-002
Source studies (1)Record ID: I-CTG-ob-002-f64eed50f8
Not recordedNot recordedother-or-unclearWITHDRAWN
Obinutuzumab
Source studies (1)Record ID: I-CTG-obinutuzumab-27a705e961
Not recordedNot recordedother-or-unclearTERMINATED
Olaparib
Source studies (1)Record ID: I-CTG-olaparib-a02f1e209b
Not recordedbinder; inhibitorconventional-cytotoxic-regimenACTIVE_NOT_RECRUITING
On-Treatment Biopsy
Source studies (1)Record ID: I-CTG-on-treatment-biopsy-2778688f6b
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
ONCR-177
Source studies (1)Record ID: I-CTG-oncr-177-b2c5097c90
Not recordedNot recordedother-or-unclearTERMINATED
Optical coherence tomography probe
Source studies (1)Record ID: I-CTG-optical-coherence-tomography-probe-bcc09f15e0
Not recordedNot recordedprocedure-or-deviceTERMINATED
Optical spectral reflectance and autofluorescence imaging
Source studies (1)Record ID: I-CTG-optical-spectral-reflectance-and-autofluor-d48d84bdf6
Not recordedmolecular-imagingmolecular-imaging-agentCOMPLETED
Osimertinib
Source studies (1)Record ID: I-CTG-osimertinib-83b1b6c8b8
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
oxaliplatin
Source studies (26)Record ID: I-CTG-oxaliplatin-217ec63088
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED / NOT_YET_RECRUITING / RECRUITING / TERMINATED / UNKNOWN / WITHDRAWN
Oxaliplatin (Eloxatin) + Fluorouracil + folinic acid
Source studies (1)Record ID: I-CTG-oxaliplatin-eloxatin-fluorouracil-folinic--25baf1aa13
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Oxaliplatin, Capecitabine
Source studies (1)Record ID: I-CTG-oxaliplatin-capecitabine-ff0e23ed84
Not recordedNot recordedconventional-cytotoxic-regimenTERMINATED
Oxaliplatin, Capecitabine, Panitumumab
Source studies (1)Record ID: I-CTG-oxaliplatin-capecitabine-panitumumab-7f1f26bbad
Not recordedNot recordedconventional-cytotoxic-regimenTERMINATED
Pabolizumab+ bevacizumab and CapeOX (bevacizumab + oxaliplatin + capecitabine)
Source studies (1)Record ID: I-CTG-pabolizumab-bevacizumab-and-capeox-bevaciz-9c1b6a42fb
Not recordedNot recordedantibodyUNKNOWN
Paclitaxel
Source studies (2)Record ID: I-CTG-paclitaxel-2662a98344
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING / TERMINATED
Palbociclib
Source studies (1)Record ID: I-CTG-palbociclib-f8ab549720
Not recordedNot recordedother-or-unclearWITHDRAWN
pancreatectomy or hepatectomy
Source studies (1)Record ID: I-CTG-pancreatectomy-or-hepatectomy-c32742d453
Not recordedNot recordedprocedure-or-deviceCOMPLETED
Panitumumab (Part 1a only)
Source studies (1)Record ID: I-CTG-panitumumab-part-1a-only-fa5aed2249
Not recordedNot recordedother-or-unclearCOMPLETED
Panitumumab + FOLFOX (DP)
Source studies (1)Record ID: I-CTG-panitumumab-folfox-dp-a74d96e257
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Panitumumab + FOLFOX (no-DP)
Source studies (1)Record ID: I-CTG-panitumumab-folfox-no-dp-c31419ac32
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Panitumumab 20 milligram/ML
Source studies (1)Record ID: I-CTG-panitumumab-20-milligram-ml-b5aa88c37a
Not recordedNot recordedother-or-unclearRECRUITING
Panitumumab with capecitabine and oxaliplatin (CAPOX) followed by
Source studies (1)Record ID: I-CTG-panitumumab-with-capecitabine-and-oxalipla-75b2d60e4a
Not recordedNot recordedconventional-cytotoxic-regimenWITHDRAWN
Panitumumab with capecitabine and radiation
Source studies (1)Record ID: I-CTG-panitumumab-with-capecitabine-and-radiatio-3c589bacfc
Not recordedNot recordedconventional-cytotoxic-regimenWITHDRAWN
PANVAC-F
Source studies (1)Record ID: I-CTG-panvac-f-cda251040f
Not recordedNot recordedother-or-unclearCOMPLETED
PANVAC-V
Source studies (1)Record ID: I-CTG-panvac-v-abadae5abc
Not recordedNot recordedother-or-unclearCOMPLETED
Paracentesis
Source studies (1)Record ID: I-CTG-paracentesis-716ce570e3
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Part 1 TPST-1120
Source studies (1)Record ID: I-CTG-part-1-tpst-1120-6adb3ad37b
Not recordedNot recordedother-or-unclearCOMPLETED
Part 2 TPST-1120 + nivolumab
Source studies (1)Record ID: I-CTG-part-2-tpst-1120-nivolumab-eed7a87307
Not recordedNot recordedother-or-unclearCOMPLETED
Part 3 TPST-1120
Source studies (1)Record ID: I-CTG-part-3-tpst-1120-12beb5165a
Not recordedNot recordedother-or-unclearCOMPLETED
Part 4 TPST-1120 + nivolumab
Source studies (1)Record ID: I-CTG-part-4-tpst-1120-nivolumab-b109e23900
Not recordedNot recordedother-or-unclearCOMPLETED
Patient Control Analgesia (PCA) Morphine
Source studies (1)Record ID: I-CTG-patient-control-analgesia-pca-morphine-86f8799359
Not recordedNot recordedother-or-unclearCOMPLETED
Patient Navigation
Source studies (1)Record ID: I-CTG-patient-navigation-a0550250d8
Not recordedNot recordedother-or-unclearRECRUITING
Patient Observation
Source studies (1)Record ID: I-CTG-patient-observation-007d5aee2e
Not recordedNot recordedother-or-unclearRECRUITING
Patritumab Deruxtecan
Source studies (1)Record ID: I-CTG-patritumab-deruxtecan-266372e24a
Not recordedNot recordedother-or-unclearTERMINATED
Pazopanib
Source studies (1)Record ID: I-CTG-pazopanib-fc47d3a172
Not recordedinhibitorother-or-unclearCOMPLETED
PB101
Source studies (1)Record ID: I-CTG-pb101-433455a932
Not recordedNot recordedother-or-unclearUNKNOWN
PCA
Source studies (1)Record ID: I-CTG-pca-4dda90e8db
Not recordedNot recordedprocedure-or-deviceUNKNOWN
PDR001
Source studies (1)Record ID: I-CTG-pdr001-ece896f523
Not recordedNot recordedother-or-unclearCOMPLETED
Pegfilgrastim
Source studies (1)Record ID: I-CTG-pegfilgrastim-f08268964f
Not recordedNot recordedother-or-unclearTERMINATED
Pegylated liposomal doxorubicin (PLD)
Source studies (1)Record ID: I-CTG-pegylated-liposomal-doxorubicin-pld-be373b3834
Not recordedbinder; inhibitorother-or-unclearTERMINATED
Pembrolizumab (MK-3475)
Source studies (1)Record ID: I-CTG-pembrolizumab-mk-3475-ef646ad129
Not recordedNot recordedother-or-unclearTERMINATED
Pemetrexed
Source studies (2)Record ID: I-CTG-pemetrexed-e1d4553852
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
Penpulimab injection
Source studies (1)Record ID: I-CTG-penpulimab-injection-7da2c3d9ca
Not recordedNot recordedantibodyUNKNOWN
PeptiCRAd-1
Source studies (1)Record ID: I-CTG-pepticrad-1-a6c55038c8
Not recordedNot recordedother-or-unclearRECRUITING
Performance status
Source studies (1)Record ID: I-CTG-performance-status-d6ee286977
Not recordedNot recordedother-or-unclearUNKNOWN
PET
Source studies (1)Record ID: I-CTG-pet-bbba57318f
Not recordedNot recordeddiagnostic-testTERMINATED
Pexa-Vec
Source studies (1)Record ID: I-CTG-pexa-vec-4e9eb29c59
Not recordedNot recordedother-or-unclearCOMPLETED
PF-05212384
Source studies (1)Record ID: I-CTG-pf-05212384-24958d3455
Not recordedNot recordedother-or-unclearTERMINATED
PF-07284892
Source studies (1)Record ID: I-CTG-pf-07284892-c7dd60dbfd
Not recordedNot recordedother-or-unclearTERMINATED
PF-07329640
Source studies (1)Record ID: I-CTG-pf-07329640-371a79391a
Not recordedNot recordedother-or-unclearTERMINATED
PF-07826390
Source studies (1)Record ID: I-CTG-pf-07826390-8e559facb7
Not recordedNot recordedbispecific-antibodyTERMINATED
PF-08032562
Source studies (1)Record ID: I-CTG-pf-08032562-669c79729c
Not recordedNot recordedother-or-unclearRECRUITING
pharmacological study
Source studies (4)Record ID: I-CTG-pharmacological-study-61a08d0ad1
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING / COMPLETED / TERMINATED
PHN-010
Source studies (1)Record ID: I-CTG-phn-010-a2f9d1e170
Not recordedcytotoxic-payload-deliveryantibody-drug-conjugateTERMINATED
Photodynamic Therapy
Source studies (1)Record ID: I-CTG-photodynamic-therapy-c27ebbabef
Not recordedNot recordedother-or-unclearRECRUITING
Photography
Source studies (1)Record ID: I-CTG-photography-25f3aeb51f
Not recordedNot recordedother-or-unclearTERMINATED
Placebo
Source studies (7)Record ID: I-CTG-placebo-9c3b89ebaf
Not recordedNot recordedconventional-cytotoxic-regimenACTIVE_NOT_RECRUITING / COMPLETED / TERMINATED / UNKNOWN / WITHDRAWN
Placebo Administration
Source studies (1)Record ID: I-CTG-placebo-administration-51232b6d97
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Placebo to vismodegib
Source studies (1)Record ID: I-CTG-placebo-to-vismodegib-54ef69d1df
Not recordedNot recordedother-or-unclearCOMPLETED
Plasma circulating DNA analysis
Source studies (1)Record ID: I-CTG-plasma-circulating-dna-analysis-6a080be6a4
Not recordedNot recordedother-or-unclearCOMPLETED
Plerixafor
Source studies (1)Record ID: I-CTG-plerixafor-0e8302753d
Not recordedNot recordedother-or-unclearTERMINATED
Pneumococcal Vaccine
Source studies (1)Record ID: I-CTG-pneumococcal-vaccine-3a286e3cff
Not recordedNot recordedvaccineTERMINATED
Polio Vaccine
Source studies (1)Record ID: I-CTG-polio-vaccine-8bd23171cc
Not recordedNot recordedvaccineTERMINATED
PolyPEPI1018
Source studies (1)Record ID: I-CTG-polypepi1018-d64b014978
Not recordedNot recordedvaccineCOMPLETED
Positron Emission Mammography
Source studies (1)Record ID: I-CTG-positron-emission-mammography-0118d1dc52
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Positron Emission Tomography
Source studies (10)Record ID: I-CTG-positron-emission-tomography-ffd4d5b3e4
Not recordedNot recordedmolecular-imaging-agentACTIVE_NOT_RECRUITING / COMPLETED / RECRUITING / TERMINATED
Postoperative dwell with paclitaxel and 5-FU
Source studies (1)Record ID: I-CTG-postoperative-dwell-with-paclitaxel-and-5--cbaf1635c9
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Pre-Treatment Biopsy
Source studies (1)Record ID: I-CTG-pre-treatment-biopsy-a90e655b1d
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Prednisone
Source studies (1)Record ID: I-CTG-prednisone-4995a7ba74
Not recordedNot recordedother-or-unclearRECRUITING
Prednisone/ prednisolone
Source studies (1)Record ID: I-CTG-prednisone-prednisolone-ab44bed919
Not recordedNot recordedother-or-unclearRECRUITING
Prochlorperazine
Source studies (1)Record ID: I-CTG-prochlorperazine-c8ee5fcc08
Not recordedNot recordedother-or-unclearCOMPLETED
Prostate-Specific Antigen Test
Source studies (1)Record ID: I-CTG-prostate-specific-antigen-test-69e1daab23
Not recordedNot recordeddiagnostic-testUNKNOWN
Proton-decoupled 31P MRS at 1.5T
Source studies (1)Record ID: I-CTG-proton-decoupled-31p-mrs-at-1-5t-d78a91489f
Not recordedNot recordedantibodyCOMPLETED
PY314
Source studies (1)Record ID: I-CTG-py314-c569282056
Not recordedNot recordedother-or-unclearTERMINATED
QL1706 Drug: mFOLFOX6 Radiation: Short-Course Radiotherapy (SCRT)
Source studies (1)Record ID: I-CTG-ql1706-drug-mfolfox6-radiation-short-cours-52e0d55470
Not recordedNot recordedbispecific-antibodyNOT_YET_RECRUITING
quality-of-life assessment
Source studies (1)Record ID: I-CTG-quality-of-life-assessment-28a9608bcf
Not recordedNot recordedprocedure-or-deviceCOMPLETED
Questionnaire
Source studies (1)Record ID: I-CTG-questionnaire-ba8850dcf4
Not recordedNot recordedother-or-unclearRECRUITING
Questionnaire Administration
Source studies (1)Record ID: I-CTG-questionnaire-administration-f956df30f2
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Radiation Therapy
Source studies (3)Record ID: I-CTG-radiation-therapy-0a178cc5e4
Not recordedNot recordedradiationACTIVE_NOT_RECRUITING / COMPLETED / TERMINATED
Radiofrequency ablation therapeutic apparatus
Source studies (1)Record ID: I-CTG-radiofrequency-ablation-therapeutic-appara-a642dca4d5
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Radiologic Examination
Source studies (1)Record ID: I-CTG-radiologic-examination-9a6ce96111
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Radiologic Imaging Procedure
Source studies (1)Record ID: I-CTG-radiologic-imaging-procedure-34b1192459
Not recordedNot recordedprocedure-or-deviceRECRUITING
Radiotherapy
Source studies (2)Record ID: I-CTG-radiotherapy-7f9e778d18
Not recordedNot recordedradiationRECRUITING / TERMINATED
Raman spectroscopy (SPECTRA IMDx)
Source studies (1)Record ID: I-CTG-raman-spectroscopy-spectra-imdx-952b1686c5
Not recordedNot recordedprocedure-or-deviceUNKNOWN
Ramucirumab Injection
Source studies (1)Record ID: I-CTG-ramucirumab-injection-5636405d75
Not recordedNot recordedother-or-unclearCOMPLETED
recombinant fowlpox-CEA(6D)/TRICOM vaccine
Source studies (1)Record ID: I-CTG-recombinant-fowlpox-cea-6d-tricom-vaccine-65049cf12c
Not recordedNot recordedvaccineCOMPLETED
Recombinant Fowlpox-GM-CSF
Source studies (1)Record ID: I-CTG-recombinant-fowlpox-gm-csf-b0118f1760
Not recordedNot recordedother-or-unclearCOMPLETED
Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
Source studies (2)Record ID: I-CTG-recombinant-nonavalent-types-6-11-16-18-31-5a6e71a614
Not recordedNot recordedvaccineCOMPLETED
Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
Source studies (1)Record ID: I-CTG-recombinant-nonavalent-human-papillomaviru-da7b49af2c
Not recordedNot recordedvaccineCOMPLETED
Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
Source studies (1)Record ID: I-CTG-recombinant-quadrivalent-human-papillomavi-36bae07401
Not recordedNot recordedvaccineCOMPLETED
Rectectomy
Source studies (1)Record ID: I-CTG-rectectomy-87902c3df2
Not recordedNot recordedprocedure-or-deviceUNKNOWN
Regorafenib (BAY 73-4506)
Source studies (1)Record ID: I-CTG-regorafenib-bay-73-4506-e8f7d047b9
Not recordedNot recordedother-or-unclearRECRUITING
Resection
Source studies (1)Record ID: I-CTG-resection-704a490aaa
Not recordedNot recordedprocedure-or-deviceRECRUITING
Resection surgery
Source studies (1)Record ID: I-CTG-resection-surgery-b8514ede44
Not recordedNot recordedprocedure-or-deviceUNKNOWN
RetroviewTM colonoscope
Source studies (1)Record ID: I-CTG-retroviewtm-colonoscope-d6b6d7ed2c
Not recordedNot recordedprocedure-or-deviceCOMPLETED
rF-CEA(6D)/TRICOM
Source studies (1)Record ID: I-CTG-rf-cea-6d-tricom-d76022ee81
Not recordedNot recordedother-or-unclearCOMPLETED
Rilvegostomig
Source studies (1)Record ID: I-CTG-rilvegostomig-51ddc4cd03
Not recordedNot recordedother-or-unclearRECRUITING
Rituximab
Source studies (1)Record ID: I-CTG-rituximab-2e49eb3c34
Not recordedNot recordedother-or-unclearCOMPLETED
RO7515629
Source studies (1)Record ID: I-CTG-ro7515629-a1f49e9aff
Not recordedNot recordedother-or-unclearTERMINATED
Rogaratinib
Source studies (1)Record ID: I-CTG-rogaratinib-f1e5447552
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
rV-CEA(6D)/TRICOM-rF-CEA(6D)/TRICOM
Source studies (1)Record ID: I-CTG-rv-cea-6d-tricom-rf-cea-6d-tricom-6ecc12eb4e
Not recordedNot recordedother-or-unclearCOMPLETED
S-1
Source studies (2)Record ID: I-CTG-s-1-6a840baf5d
Not recordedNot recordedother-or-unclearUNKNOWN / WITHDRAWN
S-1, Bevacizumab
Source studies (1)Record ID: I-CTG-s-1-bevacizumab-b11d2b44f6
Not recordedNot recordedother-or-unclearCOMPLETED
S-1, Irinotecan, Bevacizumab
Source studies (2)Record ID: I-CTG-s-1-irinotecan-bevacizumab-ed76068ac9
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
S-531011
Source studies (1)Record ID: I-CTG-s-531011-71168055f0
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
S1
Source studies (2)Record ID: I-CTG-s1-e8bc163c82
Not recordedNot recordedother-or-unclearUNKNOWN
Sampling
Source studies (1)Record ID: I-CTG-sampling-52630e4131
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
Sargramostim (GM-CSF, Leukine)
Source studies (1)Record ID: I-CTG-sargramostim-gm-csf-leukine-d29647800f
Not recordedNot recordedvaccineCOMPLETED
Screening Questionnaire Administration
Source studies (1)Record ID: I-CTG-screening-questionnaire-administration-0a65b6feb4
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Serum metabolomic analysis or ELISA
Source studies (1)Record ID: I-CTG-serum-metabolomic-analysis-or-elisa-71fe764949
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
Short Course Radiotherapy (SCRT)
Source studies (1)Record ID: I-CTG-short-course-radiotherapy-scrt-0d75e0f8f8
Not recordedNot recordedradiationCOMPLETED
Sigmoidoscopy
Source studies (1)Record ID: I-CTG-sigmoidoscopy-4dbc0d4ee1
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
single photon emission computed tomography
Source studies (1)Record ID: I-CTG-single-photon-emission-computed-tomography-fa3b449559
Not recordedNot recordedprocedure-or-deviceCOMPLETED
Sintilimab+Cetuximab+Chemotherapy (mFOLFOX6/FOLFIRI/CAPEOX/CAPIRI)
Source studies (1)Record ID: I-CTG-sintilimab-cetuximab-chemotherapy-mfolfox6-6f8c632ed7
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
Sintilimab,regofinib,cetuximab
Source studies (1)Record ID: I-CTG-sintilimab-regofinib-cetuximab-4ca21f4c71
Not recordedNot recordedother-or-unclearUNKNOWN
SIR-Sphere
Source studies (1)Record ID: I-CTG-sir-sphere-80cf50063d
Not recordedNot recordedradioligand-therapyCOMPLETED
Sir-Spheres
Source studies (1)Record ID: I-CTG-sir-spheres-bd0d6f6e70
Not recordedNot recordedradioligand-therapyCOMPLETED
SNB-101
Source studies (1)Record ID: I-CTG-snb-101-9f3414b5ea
Not recordedNot recordedother-or-unclearCOMPLETED
SNK01
Source studies (1)Record ID: I-CTG-snk01-622d96f88e
Not recordedNot recordedother-or-unclearWITHDRAWN
Sodium Valproate
Source studies (1)Record ID: I-CTG-sodium-valproate-ad466db77f
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Sofe-M
Source studies (1)Record ID: I-CTG-sofe-m-d6f06a2647
Not recordedNot recordedother-or-unclearRECRUITING
Sotigalimab
Source studies (1)Record ID: I-CTG-sotigalimab-44c2a2ac30
Not recordedNot recordedother-or-unclearENROLLING_BY_INVITATION
SPECT/CT scan
Source studies (1)Record ID: I-CTG-spect-ct-scan-f23d165d06
Not recordedNot recordedradiationUNKNOWN
Spinal
Source studies (1)Record ID: I-CTG-spinal-6676403310
Not recordedNot recordedprocedure-or-deviceUNKNOWN
Spinal analgesia
Source studies (1)Record ID: I-CTG-spinal-analgesia-c430588c7a
Not recordedNot recordedother-or-unclearCOMPLETED
SPLIT Abs
Source studies (1)Record ID: I-CTG-split-abs-568a6369c5
Not recordedNot recordedother-or-unclearRECRUITING
Standard of Care
Source studies (1)Record ID: I-CTG-standard-of-care-2154d8c49a
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
Standard of Care Anticancer Therapies
Source studies (1)Record ID: I-CTG-standard-of-care-anticancer-therapies-ca35c42b0d
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
STAR0602
Source studies (1)Record ID: I-CTG-star0602-0e31bea916
Not recordedNot recordedother-or-unclearRECRUITING
Stereotactic Body Radiation Therapy
Source studies (2)Record ID: I-CTG-stereotactic-body-radiation-therapy-50b9b943a9
Not recordedNot recordedradiationRECRUITING / WITHDRAWN
stereotactic body radiation treatment (SBRT)
Source studies (1)Record ID: I-CTG-stereotactic-body-radiation-treatment-sbrt-f2d353b710
Not recordedNot recordedradiationRECRUITING
sunitinib added to FOLFIRI
Source studies (1)Record ID: I-CTG-sunitinib-added-to-folfiri-740e02fad6
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Suntent
Source studies (1)Record ID: I-CTG-suntent-c1d3a1ed5b
Not recordedNot recordedother-or-unclearTERMINATED
Supportive treatment
Source studies (1)Record ID: I-CTG-supportive-treatment-374c0d91c4
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Surgery
Source studies (2)Record ID: I-CTG-surgery-fc00eb484b
Not recordedNot recordedprocedure-or-deviceCOMPLETED
Surgery and Radiation Therapy
Source studies (1)Record ID: I-CTG-surgery-and-radiation-therapy-1f3ec33ef0
Not recordedNot recordedprocedure-or-deviceWITHDRAWN
Surgical Procedure
Source studies (1)Record ID: I-CTG-surgical-procedure-4c06a922cd
Not recordedNot recordedprocedure-or-deviceRECRUITING
surveillance program after completion of primary treatment
Source studies (1)Record ID: I-CTG-surveillance-program-after-completion-of-p-5da708d826
Not recordedNot recordedconventional-cytotoxic-regimenCOMPLETED
Survey Administration
Source studies (1)Record ID: I-CTG-survey-administration-bb8be55b97
Not recordedNot recordedother-or-unclearRECRUITING
SY-5609
Source studies (1)Record ID: I-CTG-sy-5609-026f831140
Not recordedNot recordedother-or-unclearRECRUITING
Sym004
Source studies (3)Record ID: I-CTG-sym004-e0e4b03009
Not recordedbinderantibodyTERMINATED / WITHDRAWN
Sym004 (12 mg/kg)
Source studies (1)Record ID: I-CTG-sym004-12-mg-kg-421e2d5840
Not recordedNot recordedother-or-unclearCOMPLETED
Sym004 (9/6 mg/kg)
Source studies (1)Record ID: I-CTG-sym004-9-6-mg-kg-06c895353e
Not recordedNot recordedother-or-unclearCOMPLETED
SYN004
Source studies (1)Record ID: I-CTG-syn004-98f543afc6
Not recordedNot recordedother-or-unclearCOMPLETED
Synthetic Tumor-Associated Peptide Vaccine Therapy
Source studies (1)Record ID: I-CTG-synthetic-tumor-associated-peptide-vaccine-c83b521589
Not recordedNot recordedvaccineENROLLING_BY_INVITATION
TAA06 injection
Source studies (1)Record ID: I-CTG-taa06-injection-bab9f355e9
Not recordedNot recordedcar-t-cell-therapyUNKNOWN
TACE
Source studies (1)Record ID: I-CTG-tace-1c10c95381
Not recordedNot recordedprocedure-or-deviceCOMPLETED
Tailored surgery
Source studies (1)Record ID: I-CTG-tailored-surgery-c768a57377
Not recordedNot recordedprocedure-or-deviceTERMINATED
Talimogene Laherparepvec
Source studies (1)Record ID: I-CTG-talimogene-laherparepvec-7f8686419b
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING
TAS-102
Source studies (6)Record ID: I-CTG-tas-102-0cc3712f32
Not recordedNot recordedother-or-unclearCOMPLETED / NOT_YET_RECRUITING / RECRUITING
TAS-115
Source studies (1)Record ID: I-CTG-tas-115-4a45b73319
Not recordedNot recordedother-or-unclearRECRUITING
TAS-116
Source studies (1)Record ID: I-CTG-tas-116-d30001104c
Not recordedNot recordedother-or-unclearRECRUITING
TAS-120
Source studies (1)Record ID: I-CTG-tas-120-05739c5158
Not recordedNot recordedother-or-unclearRECRUITING
TB511
Source studies (1)Record ID: I-CTG-tb511-1f505b7653
Not recordedbinderother-or-unclearNOT_YET_RECRUITING
TC-510
Source studies (1)Record ID: I-CTG-tc-510-9b1833ab76
Not recordedNot recordedother-or-unclearTERMINATED
Temozolomide
Source studies (3)Record ID: I-CTG-temozolomide-fb2da10619
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING / UNKNOWN
Tepotinib
Source studies (1)Record ID: I-CTG-tepotinib-3d05149ad4
Not recordedNot recordedother-or-unclearTERMINATED
Texture and Color Enhancement Imaging (TXI) and Red Dichromatic Imaging (RDI)
Source studies (1)Record ID: I-CTG-texture-and-color-enhancement-imaging-txi--eb14ffad61
Not recordedNot recordedother-or-unclearWITHDRAWN
TF2/IMP288
Source studies (1)Record ID: I-CTG-tf2-imp288-e51344a77e
Not recordedNot recordedother-or-unclearWITHDRAWN
The P1 Check-Cap capsule
Source studies (1)Record ID: I-CTG-the-p1-check-cap-capsule-c18b3f27b1
Not recordedNot recordedprocedure-or-deviceTERMINATED
therapeutic autologous dendritic cells
Source studies (1)Record ID: I-CTG-therapeutic-autologous-dendritic-cells-5fb7aea80f
Not recordedNot recordedcellular-therapyCOMPLETED
therapeutic autologous lymphocytes
Source studies (1)Record ID: I-CTG-therapeutic-autologous-lymphocytes-df7f58a66d
Not recordedNot recordedother-or-unclearCOMPLETED
Therapeutic Conventional Surgery
Source studies (2)Record ID: I-CTG-therapeutic-conventional-surgery-338b35cbac
Not recordedNot recordedprocedure-or-deviceTERMINATED / WITHDRAWN
tissue biopsy
Source studies (1)Record ID: I-CTG-tissue-biopsy-4563eb941c
Not recordedNot recordedother-or-unclearRECRUITING
TLR8 Agonist VTX-2337
Source studies (1)Record ID: I-CTG-tlr8-agonist-vtx-2337-94adde9273
Not recordedagonistother-or-unclearTERMINATED
TME surgery
Source studies (1)Record ID: I-CTG-tme-surgery-574b272c1c
Not recordedNot recordedconventional-cytotoxic-regimenNOT_YET_RECRUITING
TMT212
Source studies (1)Record ID: I-CTG-tmt212-c2703c9f1c
Not recordedNot recordedother-or-unclearCOMPLETED
Total Mesorectal Excision
Source studies (1)Record ID: I-CTG-total-mesorectal-excision-05ac87e6b3
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Total mesorectal excision (TME)
Source studies (1)Record ID: I-CTG-total-mesorectal-excision-tme-cfef43fa3a
Not recordedNot recordedprocedure-or-deviceTERMINATED
TQB2101 for injection
Source studies (1)Record ID: I-CTG-tqb2101-for-injection-9460dec982
Not recordedcytotoxic-payload-deliveryantibody-drug-conjugateNOT_YET_RECRUITING
Trametinib
Source studies (1)Record ID: I-CTG-trametinib-fd739ca975
Not recordedNot recordedother-or-unclearCOMPLETED
Trastuzumab-Deruxtecan (T-DXd)
Source studies (1)Record ID: I-CTG-trastuzumab-deruxtecan-t-dxd-094319d6cd
Not recordedNot recordedother-or-unclearRECRUITING
TRC102
Source studies (1)Record ID: I-CTG-trc102-33d32944bb
Not recordedNot recordedother-or-unclearCOMPLETED
Tremelimumab
Source studies (1)Record ID: I-CTG-tremelimumab-b96a065b39
Not recordedNot recordedother-or-unclearCOMPLETED
TRICOM-CEA(6D)
Source studies (1)Record ID: I-CTG-tricom-cea-6d-a240edb949
Not recordedNot recordedcellular-therapyCOMPLETED
Trifluridine + Tipiracil
Source studies (1)Record ID: I-CTG-trifluridine-tipiracil-bc0eab59a7
Not recordedNot recordedconventional-cytotoxic-regimenRECRUITING
Trifluridine and Tipiracil Hydrochloride
Source studies (1)Record ID: I-CTG-trifluridine-and-tipiracil-hydrochloride-54105ecac7
Not recordedNot recordedother-or-unclearWITHDRAWN
Trifluridine-Tipiracil
Source studies (2)Record ID: I-CTG-trifluridine-tipiracil-0ce439aa95
Not recordedNot recordedother-or-unclearRECRUITING
Trifluridine/Tipiracil
Source studies (2)Record ID: I-CTG-trifluridine-tipiracil-0032e66d66
Not recordedNot recordedother-or-unclearCOMPLETED / RECRUITING
Trifluridine/tipiracil (TAS-102) combined with bevacizumab and ptemizumab
Source studies (1)Record ID: I-CTG-trifluridine-tipiracil-tas-102-combined-wi-6cfdffa038
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
Trifluridine/tipiracil + bevacizumab
Source studies (1)Record ID: I-CTG-trifluridine-tipiracil-bevacizumab-deb2085f44
Not recordedNot recordedother-or-unclearRECRUITING
Trifluridine/Tipiracil + Regorafenib
Source studies (1)Record ID: I-CTG-trifluridine-tipiracil-regorafenib-1dbf1c0555
Not recordedNot recordedother-or-unclearRECRUITING
Trifluridine/Tipiracil Hydrochloride
Source studies (1)Record ID: I-CTG-trifluridine-tipiracil-hydrochloride-7dd4f1b568
Not recordedNot recordedother-or-unclearRECRUITING
Trifluridine/tipiracil hydrochloride (S 95005)
Source studies (1)Record ID: I-CTG-trifluridine-tipiracil-hydrochloride-s-950-acc4c34069
Not recordedNot recordedother-or-unclearCOMPLETED
Tripleitriumab
Source studies (1)Record ID: I-CTG-tripleitriumab-75cead04cb
Not recordedNot recordedother-or-unclearUNKNOWN
TSR-033
Source studies (1)Record ID: I-CTG-tsr-033-9cd9a29917
Not recordedNot recordedantibodyCOMPLETED
TTX-MC138
Source studies (1)Record ID: I-CTG-ttx-mc138-2165742de0
Not recordedNot recordedother-or-unclearRECRUITING
Tumor Infiltrating Lymphocytes (TIL)
Source studies (1)Record ID: I-CTG-tumor-infiltrating-lymphocytes-til-8887df852c
Not recordedNot recordedother-or-unclearRECRUITING
Tumor specific mesorectal excision
Source studies (1)Record ID: I-CTG-tumor-specific-mesorectal-excision-a965cbf0f1
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Tumor Tissue Collection and NGS
Source studies (1)Record ID: I-CTG-tumor-tissue-collection-and-ngs-d22cb69308
Not recordedNot recordeddiagnostic-testRECRUITING
Tumor tissue sampling for organoid development
Source studies (1)Record ID: I-CTG-tumor-tissue-sampling-for-organoid-develop-e81a9022da
Not recordedNot recordedprocedure-or-deviceRECRUITING
UCB4594
Source studies (1)Record ID: I-CTG-ucb4594-3b78bd6490
Not recordedNot recordedother-or-unclearRECRUITING
UFT
Source studies (1)Record ID: I-CTG-uft-94cca6fdcf
Not recordedNot recordedother-or-unclearCOMPLETED
Ultrasound Imaging
Source studies (1)Record ID: I-CTG-ultrasound-imaging-8ed1941328
Not recordedNot recordedprocedure-or-deviceACTIVE_NOT_RECRUITING
Vectibix® (panitumumab)
Source studies (1)Record ID: I-CTG-vectibix-panitumumab-33e4583e2c
Not recordedbinderantibodyCOMPLETED
vemurafenib
Source studies (2)Record ID: I-CTG-vemurafenib-a383bf2e3e
Not recordedNot recordedother-or-unclearCOMPLETED
Venetoclax
Source studies (1)Record ID: I-CTG-venetoclax-87ebc9d39b
Not recordedNot recordedother-or-unclearCOMPLETED
virtual chromo-endoscopy using FICE Fujifilm Technology
Source studies (1)Record ID: I-CTG-virtual-chromo-endoscopy-using-fice-fujifi-7ac4ba6b09
Not recordedNot recordedprocedure-or-deviceUNKNOWN
Virtual Chromoendoscopy
Source studies (1)Record ID: I-CTG-virtual-chromoendoscopy-5711d066c1
Not recordedNot recordedprocedure-or-deviceNOT_YET_RECRUITING
Vismodegib 150 mg
Source studies (1)Record ID: I-CTG-vismodegib-150-mg-0d5cf702a9
Not recordedNot recordedother-or-unclearCOMPLETED
Vitamin A
Source studies (2)Record ID: I-CTG-vitamin-a-2b6a15c1b9
Not recordedNot recordedother-or-unclearUNKNOWN
Volrustomig
Source studies (1)Record ID: I-CTG-volrustomig-94a09116dd
Not recordedNot recordedother-or-unclearRECRUITING
VS-7375
Source studies (1)Record ID: I-CTG-vs-7375-6fa272ceb8
Not recordedinhibitorsmall-moleculeRECRUITING
XELOX intensive treatment group
Source studies (1)Record ID: I-CTG-xelox-intensive-treatment-group-cee89b6967
Not recordedNot recordedother-or-unclearRECRUITING
XmAb®23104
Source studies (1)Record ID: I-CTG-xmab23104-e90fd3738f
Not recordedNot recordedbispecific-antibodyCOMPLETED
xT-Onco with HLA-LOH Assay
Source studies (1)Record ID: I-CTG-xt-onco-with-hla-loh-assay-c4c1cf9999
Not recordedNot recordeddiagnostic-testACTIVE_NOT_RECRUITING
Yervoy® (ipilimumab)
Source studies (1)Record ID: I-CTG-yervoy-ipilimumab-11ea2964c9
Not recordedNot recordedantibodyCOMPLETED
YMN-A02 1000μg
Source studies (1)Record ID: I-CTG-ymn-a02-1000-g-8bb463fc63
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
YMN-A02 100μg
Source studies (1)Record ID: I-CTG-ymn-a02-100-g-c78b72bc51
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
YMN-A02 250μg
Source studies (1)Record ID: I-CTG-ymn-a02-250-g-d0918ed5ef
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
YMN-A02 500μg
Source studies (1)Record ID: I-CTG-ymn-a02-500-g-75e7f8f1cb
Not recordedNot recordedother-or-unclearNOT_YET_RECRUITING
Yttrium-90 Radioembolization with standard systemic therapy
Source studies (1)Record ID: I-CTG-yttrium-90-radioembolization-with-standard-aaed2e60d5
Not recordedNot recordedradioligand-therapyNOT_YET_RECRUITING
Zalutumumab
Source studies (1)Record ID: I-CTG-zalutumumab-086552ae75
Not recordedNot recordedother-or-unclearTERMINATED
Zanzalintinib
Source studies (1)Record ID: I-CTG-zanzalintinib-6d6ea5e2a7
Not recordedNot recordedother-or-unclearRECRUITING
ZD6474
Source studies (1)Record ID: I-CTG-zd6474-67e2d836a2
Not recordedNot recordedother-or-unclearCOMPLETED
Ziv-Aflibercept
Source studies (1)Record ID: I-CTG-ziv-aflibercept-cb86c45d5b
Not recordedNot recordedother-or-unclearACTIVE_NOT_RECRUITING

Treatment data

Directness, disease context, development state, dates, and source references remain in the JSON record.

Search the report